Synthesis And Characterization Of A Physically Entangled Dna Hydrogel And Its Applications by Peng, Songming
  
 
SYNTHESIS AND CHARACTERIZATION OF A PHYSICALLY ENTANGLED 
DNA HYDROGEL AND ITS APPLICATIONS 
 
 
 
 
 
 
 
 
A Dissertation 
Presented to the Faculty of the Graduate School 
of Cornell University 
In Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy 
 
 
 
 
 
 
by 
Songming Peng 
August 2014
  
 
 
 
 
 
 
 
 
 
 
 
© 2014 Songming Peng
  
SYNTHESIS AND CHARACTERIZATION OF A PHYSICALLY ENTANGLED 
DNA HYDROGEL AND ITS APPLICATIONS 
 
Songming Peng, Ph. D.  
Cornell University 2014 
 
DNA is commonly viewed as a genetic material in all life forms, which is responsible 
for storing and encoding genetic information. However, from a materials perspective, 
DNA is an inherently generic polymeric material. Since this generic material is 
derived from biology, it has many unique properties that are not possessed by any 
other materials, including molecular recognition capability, defined base composition, 
and precise manipulation by enzymes. These properties have enabled extensive usage 
of DNA in nanotechnology for creating delicate DNA nanostructures as well as 
assembling nanomaterials. For real-world applications, however, it is necessary and 
important to create DNA materials in bulk-scale. Therefore, special attention needs to 
be paid to the efficiency and the yield for the synthesis of DNA materials. 
Unfortunately, these two objectives have not been fully explored in the field. In this 
thesis, I present a novel method to create a bulk-scale physically entangled DNA 
hydrogel. By designing two enzymatic processes, rolling circle amplification and 
multi-primed chain amplification, DNA chains are greatly amplified, both in length 
and in quantity, to entangle with each other to form a DNA hydrogel. Due to the 
power of enzymatic amplification, a bulk-scale hydrogel is easily produced with low 
cost and readily to be scaled up. Interestingly, our DNA hydrogel possesses properties 
 that are not found in nature of any kind: it has both solid-like and liquid-like 
properties. When the gel is immersed in water, it memorizes its original shape and 
behaves like a solid. However, the hydrogel become free-flowing “liquid” after taken 
out of water, and metamorphoses back to its original shape upon addition of water. 
More interestingly, the hydrogel is composed of uniformly sized DNA microspheres. 
To our surprise, the DNA density in each microsphere reaches as high as the human 
chromosome density. Thus, the DNA microsphere effectively concentrates 
unprecedentedly high dose DNA drugs that have never been achieved. This super-
condensed ultra-high dose DNA effectively protects the condensed DNA, efficiently 
enters the cell and releases the DNA, enabling a superior therapeutic effect. This 
condensed DNA format is potential to serve as a versatile platform to compact and 
deliver all DNA-based therapeutics.  
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CHAPTER 1: INTRODUCTION 
 
1.1 DNA as a generic material 
 DNA is commonly viewed as a genetic material in all life forms, which is 
responsible for storing and encoding genetic information. However, from materials 
science and engineering perspective, DNA can be treated as a generic polymer 
composed of four different deoxy-nucleoside monomers: Adenine (A), Thymine (T), 
Guanine (G), and Cytosine (C). These four monomers are connected by the 
phosphodiester bonds to form a polymer chain, which is termed single-stranded DNA 
(ssDNA, Figure 1.1). Unlike conventional polymers in which the monomer sequences 
are randomly distributed, the base arrangement in the DNA chains can be specifically 
designed and precisely controlled. Typically, one end of the DNA strand contains a 
phosphate group on the 5’ carbon of the sugar ring (defined as the 5’ end), while the 
other end has a hydroxyl group on the 3’ carbon of the sugar ring (defined as the 3’ 
end). Since DNA is derived from biology, it possesses many unique properties that are 
not owned by any other materials.  
 Biologically, DNA has the molecular recognition capability at the nanoscale. If 
two ssDNAs are complementary, they will be able to recognize each other and 
hybridize into a double-stranded DNA (dsDNA) in anti-parallel directions (one strand 
from 5’ to 3’ and the other from 3’ to 5’) through the base paring rules (i.e., A pairs 
with T and G pairs with C, Figure 1.1). This property can be used to control molecular 
recognition of different DNA chains. For instance, by designing the sequence of 
ssDNAs to be either complementary or non-complementary, different ssDNAs can 
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either hybridize into dsDNA or remain in the ssDNA form. In addition, DNA 
hybridization is entirely reversible: dsDNA can be separated into two ssDNAs at 
elevated temperature (a process called denaturing) and the separated ssDNAs can be 
re-hybridized to the dsDNA at lower temperature (a process called renaturing). This 
reversible feature allowed the possibility of using temperature to regulate DNA states 
(ssDNA or dsDNA).   
 In addition, a myriad of enzymes can be employed to precisely manipulate 
DNA at the molecule level
1-3
. For example, a ligase can covalently link two pieces of 
DNA together (Figure 1.2). On the other hand, an endonuclease can cleave one piece 
of DNA into two pieces at specific sequences (Figure 1.2). A polymerase can elongate 
one DNA using the other DNA as a template (Figure 1.2). Till now, more than one 
thousand enzymes have been discovered that can be utilized to precisely manipulate 
DNA at the angstrom level
2, 4, 5
. These enzymes provide a versatile toolbox to engineer 
DNA materials for specific applications.  
 Chemically, DNA can be easily synthesized and modified. Virtually, any DNA 
sequence can be synthesized with high monodispersity, using technologies such as 
solid-state synthesis techniques
6, 7
 and recombinant DNA technology
7
. The error rate 
of the synthesized DNA can be as low as 1 per 10 000 nucleotides
7, 8
. In addition, 
many chemical moieties such as primary amines, alkynes, thiols and biotins can be 
easily attached to the 5’ or 3’ end groups of DNA strands2. The modified DNA can be 
easily conjugated with other materials such as proteins
9-16
, polymers
17-22
, and gold 
nanoparticles
23-30
 to build hybrid materials.  
 Physically, each helical turn of dsDNA consist of ten base pair (bp) with the 
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length of 3.4 nm, and the width of 2 nm. Surprisingly, the Young’s modulus of DNA 
strands is as high as the Plexiglass
31, 32
, allowing long DNA chains in the range of 
micrometers (thousands of bps) to be used despite its diameter of 2 nm. Moreover, the 
rigidity of DNA chains can be easily tuned by changing the length of DNA or states of 
DNA (dsDNA or ssDNA). In general, dsDNA shorter than 150 bp (which is the 
persistence length of DNA, approximately 50 nm)
33
 is very rigid, while dsDNA is 
flexible when it is longer than the persistence length. On the other hand, ssDNA has a 
persistence length of about 1 nm
34
 (corresponds to 1-3 base), thus, most ssDNAs are 
flexible. These properties provide a simple strategy to tailor the flexibility and rigidity 
of a desired DNA structure by adjusting the length of DNA or the composition of 
ssDNA and dsDNA.  
Due to these unique properties, DNA has been extensively employed to build a 
variety of well-controlled and sophisticated nano-scale structures and devices
35-54
, 
such as DNA cube
38
, DNA smiley face
41
, and DNA buckyball
44
. In addition, DNA has 
been utilized as a nano-organizer to assemble inorganic nanoparticle to form one-
dimensional (1-D) polymers
55-57
, two-dimensional (2-D) lattices
23, 24, 58, 59
 and three-
dimensional (3-D) crystals
25, 28, 30, 60, 61
. In light of these achievements, however, most 
of these structures were hard to scale up due to the high error rate and low yield of 
self-assembly
36, 51, 54
. Among many challenges, bulk-scale preparation is essential for 
the applications of DNA materials. In this thesis, I will focus on the methods of 
creating bulk-scale DNA materials and their biomedical applications. 
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Figure 1.1. DNA as a polymer and the base pairing rules. A DNA polymer is 
composed of phosphodiester bonds, with four different bases (i.e. A, T, G, and C) 
dangling on the backbone. Two DNA polymers can antiparallelly hybridize with each 
other to form a dsDNA following the base paring rules (A with T and G with C).  
 
 
Figure 1.2. Enzymatic manipulation on DNA. Ligase links two pieces of DNA 
together (a), while endonuclease cuts one DNA into two pieces at specific sequence 
(b). Polymerase elongates one DNA strand using the other one as a template (c).  
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1.2 Linear DNA-based bulk materials and their applications 
Linear DNA, which includes both ssDNA and dsDNA, is the natural DNA 
topology. It has been widely used as molecular probes for DNA detection. In addition, 
DNA can be easily conjugated to different functional moieties, including 
nanoparticles, proteins and polymers, to create hybrid materials. These DNA-hybrids 
possess the attributes of both DNA and the other material, enabling the creation of 
novel materials with new functions. Moreover, the DNA-hybrids can be precisely 
arranged in the nanoscale by other DNA templates to achieve higher ordered 
structures and new applications.  
As one of the early attempts of using DNA as a generic material, Mirkin and 
co-workers pioneered in functionalizing gold nanoparticles (AuNP) with thiol 
modified DNA and organizing the AuNPs into macroscopic materials
26, 62
. They 
further applied the DNA functionalized AuNP for highly sensitive, colorimetric DNA 
detection
26, 63
. They first functionalized the AuNPs with two different thiolated 
ssDNAs, each with a partial complementary sequence to the target DNA. Without 
target DNA, the AuNPs were homogenously dispersed in the solution, showing a 
reddish color. However, when the target DNA was present, the AuNPs were brought 
together to form aggregates by the DNA hybridization. The close proximity of the 
AuNPs changed the solution from red color to purple color due to a red shift in the 
surface plasmon resonance of the AuNPs (Figure 1.3). The colorimetric change 
enabled a detection limit as low as 10 femtomoles of target DNA with naked eyes. 
More interestingly, the aggregates exhibited a sharp melting transition (from 
aggregates to solution at high temperature), allowing one to distinguish target DNA 
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sequence that contained one base mismatch, deletion or insertion from the fully 
complementary targets. In addition to AuNPs, DNA has been utilized to organize 
other nanomaterials including quantum dots
64-67
, carbon nanotubes
68-71
 for creation of 
multiplexed detection platform and development of semiconductor devices. 
To further explore the molecular recognition capability of linear DNA, it was 
used to precisely control the placement and assembly of proteins at the nanoscale. 
Niemeyer and coworkers demonstrated this concept by using the DNA as a template to 
arrange DNA-protein (i.e. streptavidin) conjugates to form the protein arrays
72
. This 
approach was further applied to fabricate multi-enzyme complexes (MEC) by 
attaching multiple enzymes to a linear DNA template
73
. The MEC greatly enhanced 
the multi-step catalytic efficiencies due to the close proximity of these enzymes. 
Specifically, two enzymes (oxidoreductase and luciferase), which catalyzed two 
consecutive reaction steps, were first conjugated to linear DNA. The formed DNA-
protein hybrids were then brought together by a complementary DNA template to 
form the MEC, allowing the consecutive reaction to occur more efficiently (Figure 
1.4). Indeed, the resulted MEC showed a three-fold increase in catalytic efficiency 
compared to a random distribution of enzymes in solution. Similar concepts have been 
used to enhance the catalytic activity of other enzymes including glucose oxidase and 
horseradish peroxidase
11, 74
. This technique of DNA-directed assembly of proteins is 
extremely useful for developing enhanced catalytic systems for biomedical and 
biological applications
14, 15, 75
. 
The aforementioned examples have fully taken advantage of molecular 
recognition capability of DNA in the DNA-protein hybrids. On the other hand, 
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proteins, especially antibodies, carry many biological functions, including antigen 
recognition and binding. By utilizing the antibody function in the DNA-antibody 
conjugate, Cantor and colleagues developed immuno-polymerase chain reaction 
(Immuno-PCR), which has enabled ultrasensitive antigen detection
9, 10, 76
. In detail, 
DNA was first conjugated to monoclonal antibody to form the DNA-antibody hybrid. 
The hybrid bound specifically to an antigen, forming the antigen-antibody-DNA 
complex. Then, the DNA was amplified by PCR to greatly increase the signal that 
indicated the presence of the target antigen (Figure 1.4). Due to the specificity and 
amplification power of PCR, the detection limit for Immuno-PCR was 100 - 10 000-
fold more sensitive than that of enzyme-linked immunosorbent assays (ELISA)
77
. This 
technique can be potentially applied detect a signal antigen molecule, enabling a broad 
range of applications in immunological research and clinical diagnostics
9, 77, 78
. 
In addition to assemble nanoparticles and proteins, DNA has also been used to 
synthesize novel copolymers
20
. The linear DNA can be designed either into the 
backbone to form block copolymers
21, 79
 or into the side chain to from DNA-polymer 
brushes. For example, Herrmann and coworkers attached one or two ssDNAs to 
polyethylene glycol (PEG) polymer to form DNA-polymer hybrids (i.e. ssDNA-PEG, 
and ssDNA-PEG-ssDNA). These hybrids were then assembled to different block 
copolymers, including PEG-dsDNA-PEG, PEG-dsDNA-PEG-dsDNA-PEG and PEG-
dsDNA-PEG-dsDNA-PEG-dsDNA-PEG
79
. Theoretically, the PEG-DNA block can be 
repeated as many times as wanted to generate super molecular weight block 
copolymers. Interestingly, the DNA length in the block copolymer can be easily 
elongated with enzymatic reactions such as PCR
21
. In addition, the PEG can be easily 
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changed to other polymers including polystyrene and polypropylene oxide to produce 
amphiphilic DNA block polymers
80, 81
. These amphiphilic polymers self-assembled 
into the nanoscale micelle in solution, which can effectively load the hydrophobic 
chemotherapeutic drugs such as doxorubicin and efficiency enter and kill the cancer 
cells
82
.  
One the other hand, when the DNA is attached to the backbone of the polymer, 
a brush DNA-polymer is created. Since the DNA adopts ssDNA state in the brush 
polymer, it can recognize other complementary ssDNA to form higher ordered 
structures such as DNA-based hydrogel. Langrana and coworker have produced two 
brush DNA-acrylamide polymers by separately copolymering two different acrydite-
functionalized DNAs with acrylamide monomers
83
. In the presence of a linker DNA, 
which was partially complementary to the two ssDNAs, those two different brush 
DNA-polymers were brought together to form a DNA-based hydrogel. In this system, 
the three hybridized DNA strands replace the traditional chemical crosslinkers. Due to 
the reversibility property of DNA hybridization, the hydrogel crosslinking is 
reversible, either by high temperature to denature the hybridized DNA, or by specific 
removal DNA strands which have a higher affinity to the linker DNA (Figure 1.5). 
This switchable hydrogel has been used as a stimuli responsive material in controlled 
release of nanoparticles
84, 85
 and proteins
86, 87
 for therapeutic applications. Recently, 
Liu and coworker further adopted this DNA-based hydrogel for ultrasensitive 
colorimetric mercury detection and removal in water
88-90
. In this application, ssDNA 
was specially designed to contain many thymine bases, two of which could bind to 
Hg
2+
. In the absence of Hg
2+
, the hydrogel showed yellow fluorescence, upon addition 
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of SYBR Green I dye. However, in the presence of Hg
2+
, the selective biding of Hg
2+ 
between two thymine bases induced the formation of a hairpin structure, which 
allowed the intercalation of SYBR Green I dye into the DNA. Thus, the hydrogel 
changed from yellow fluorescence to green fluorescence. This sensor was successfully 
used to detect and remove Hg
2+
 from samples of Lake Ontario water spiked with 
mercury. 
For the purpose of discussion, we distinguish DNA-based hydrogel and DNA 
hydrogel. In DNA-based hydrogel, DNA adopts a liner topology and serves only as a 
crosslinking role in the hydrogel formation. Since the function of these DNA is 
presented by the hybridization of linear DNA, we categorized DNA-based hydrogel in 
the linear DNA-based bulk materials. In contrast, in the DNA hydrogel, the DNA 
consists of the scaffold of the material in which DNA is linked with each other to form 
a three dimensional network structure. Thus, we categorized DNA hydrogel under 
network topology.  
Besides assembling proteins, polymers and nanoscale materials, more recently, 
Khademhosseini, Yin and coworkers has demonstrated the power of DNA to assemble 
macroscopic objects
91
, furthering proving the capability of DNA as a generic material. 
Specifically, short DNA strands (48 nt) were first modified with PEG-acylate to 
introduce crosslinkable group into the DNA. The modified DNA was then 
copolymerized with PEG diacrylate in square holes, forming 250×250×250 m 
hydrogel cubes. The DNA on the surface of the hydrogel was then amplified with 
rolling circle amplification to produce giant long ssDNAs. When hydrogel cubes 
carrying complementary giant DNA strands (48 nt) were mixed together, they 
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assembled into aggregates (Figure 1.6). This giant-DNA-dependent nature of the 
assembly was further verified by the DNA degradation experiment in which the 
aggregates became dispersed after DNase treatment, proving the assembly was indeed 
due to the giant DNA on the hydrogel surface. The DNA assisted assembly of 
macroscopic hydrogels enable the possibility of creating complex self-assembled 
macro-structures for diverse biomedical application such as patterned cell culture, 
controlled cell interactions and tissue engineering. For instance, by encapsulating 
specific different cells inside each hydrogel, the self-assembled structures could be 
utilized to build the basic architectures of native tissues
91
. 
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Figure 1.3. DNA functionalized AuNP for highly sensitive and colorimetric DNA 
detection. AuNPs are first modified with different thiolated ssDNAs. In the presence 
of complementary target DNA, DNA functionalized AuNPs will form aggregates (A), 
resulting in a solution color change from red to purple (B). The solution-to-
aggregation transition is reversible by controlling the temperature. The aggregates 
show a sharp melting transition monitored by UV-vis spectroscopy (C). 
26, 62
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Figure 1.4. Schematic illustration of applications of protein–DNA conjugates. (A) 
Construction of the artificial multi-enzyme complexes. Two DNA-enzyme hybrids are 
obtained by conjugating different enzymes to two linear DNA strands. Upon the 
addition of the DNA template, they are assembled to form the multi-enzyme 
complexes. Since the product of enzyme 1 serves as the substrate for enzyme 2, the 
proximity of these two enzymes exhibits a much higher catalytic efficiency compared 
to a random distribution of enzymes in solution. (B) Immuno-PCR for detection of 
antigen. The DNA-antibody conjugate specifically recognizes and binds to the target 
antigen. Then the DNA is greatly amplified by PCR, indicating the presence of 
antigen and achieving ultra-low detection limit. 
2, 9, 73
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Figure 1.5. Stimuli responsive gel to solution transition of DNA-functionalized 
hydrogels. ssDNAs are attached to the backbone to polymers to form a DNA-brush 
polymer. In the presence of a linker DNA, the brush-polymers are brought together to 
form a DNA-based hydrogel. The hydrogel formation is reversible due to the 
reversibility of the DNA hybridization. Different stimuli can be used to induce the gel 
to solution transition. (A) Transition is induced by change of temperature in which the 
hybridized dsDNA are denatured to adopt ssDNA state.  (B) Transition can also be 
induced by the complementary DNA, which has a higher affinity to the linker DNA 
strand.
83, 89
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Figure 1.6. DNA guided macroscopic hydrogel assembly. (A). Giant DNA containing 
tandem repeats of complementary 48-nt sequences was amplified on the surface of red 
and blue hydrogel cubes. Hybridization between the complementary DNA sequences 
resulted in the hydrogel assembly. (B). Red and blue hydrogel cubes carrying 
complementary short DNA strands failed to assemble into aggregates (left), while 
hydrogels with giant DNA succeeded to do so (right), in the presence of yellow 
hydrogels that were not modified with DNA. (C) Aggregates assembled from red and 
blue hydrogels carrying giant DNA fell apart after 1 h DNase treatment (left: before 
DNase treatment; right: after DNase treatment). Scale bar, 500 μm.91 
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1.3 Branched DNA-based bulk materials and their applications 
While promising and widely used, linear DNA is limited by its linear structure 
and topology as a material building block. To overcome these constraints, branched 
DNA has been developed. The branched DNA extended the DNA topology from one 
dimension to two dimensions, bringing many unique advantages that cannot be 
achieved by linear DNA. For example, branched DNA is inherently multivalent, 
allowing the design of various functional moieties on different branches. In addition, 
branched DNA can be engineered to be either isotropic or anisotropic by simply 
selecting different sticky-ends for each branch. Moreover, hybridization and ligation 
of branched DNA structure can result more complex 2-D and 3-D DNA structures.  
Towards that end, our group developed branched Y-shaped, T-shaped and X-
shaped DNA structures
92
. More specifically, Y-shaped DNA was achieved by 
designing three ssDNAs (Ya, Yb and Yc) to be partially complementary to each other. 
When those ssDNAs were mixed with equal moles, they recognized each other and 
assembled into a Y-shaped DNA (Y-DNA) with close to 100 % yield (Figure 1.7). T-
shaped and X-shaped DNA were also synthesized in a similar manner. In order to 
achieve a higher-generation branched DNA structure, sticky ends, which are the 
single-stranded overhangs at the ends of dsDNA, are designed to each arm of the Y-
DNA. An important concept for sticky ends design is palindromic versus non-
palindromic sequences. Palindromic sticky ends contain the same 5’ to 3’ sequence as 
their complementary DNA sequences. For instance, 5’-GAATTC-3’ has the exact 
same sequence as its complementary strand, which is 5’-GAATTC-3’, thus allowing 
for self-hybridization. On the other hand, non-palindromic sticky ends are not self-
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complementary, inhibiting the formation of the self-hybridized structure. To better 
control the branched DNA structure, non-palindromic sticky ends were chose for the 
core Y-DNA (G0). Another three peripheral Y-DNAs, which had a complementary 
sticky end to the core Y-DNA, were ligated to the core to form the first generation of 
dendrimer-like DNA (DL-DNA, G1). Similarly, higher generation structures were 
produced by repeatedly ligating peripheral Y-DNAs to the previous generation 
(Figrure 1.7).  
The DL-DNA possesses the advantages of traditional chemical dendrimers, 
such as tunable size, diverse architecture, and availability of multiple surface groups 
(multivalency), which can be achieved by altering the composition and length of the 
individual Y-DNA building blocks comprising the DL-DNA. In fact, the fine 
tunability on the size of DL-DNA in the nanoscale has been utilized to reveal 
structural requirements for IgE receptor signaling in mast cells
93
. More importantly, 
the synthesis of DL-DNA was catalyzed by the T4 ligase enzyme, giving close to 100 
% yield, which enabled to create the DL-DNA in bulk scale. In addition, DL-DNA 
spans a greater range of diameters than traditional dendrimers. For example, DL-DNA 
can reach a size of 50 nm in the second generation, while PAMAM dendrimers can 
only reach 11 nm in the ninth generation
94
. This dendrimer structure and broad size 
range can greatly enhance the DL-DNA diffusion speed and facilitate endocytosis by 
cells
95
. Moreover, the degraded products of the DNA are nucleotides, which are 
naturally occurring metabolites in the body-rendering the DL-DNA non-toxic and 
biocompatible. These properties render the DL-DNA a superior candidate for 
biomedical applications.  
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Indeed, the DL-DNA structure has been successfully utilized for biomedical 
applications such as multiplexed diagnosis
96-98
, vaccine and drug delivery
93, 99-101
. In 
particular, our lab reported a DL-DNA based fluorescence nanobarcode for 
multiplexed detection of pathogen DNA
96, 102
. The nanobarcode consisted of first 
generation DL-DNA with varying modified branches, each labeled with unique 
fluorescence dyes (green or red) or molecular probes (Figure 1.8). By controlling the 
number of the green/red fluorescent dyes, multi-colored nanobarcodes were created, 
allowing multiplexed detection of different bacterial pathogen DNAs simultaneously. 
We demonstrated that the DNA nanobarcodes were able to simultaneously detect four 
different pathogen DNA (i.e. Bacillus anthracis, Francisella tularensis, Ebola virus 
and the severe acute respiratory syndrome (SARS) coronavirus) with attomole 
sensitivity in less than a minute. The results demonstrated that the DL-DNA can be 
used as both structure scaffolds and functional diagnostic probes.  
More recently, the DNA barcode has been extended from a DNA detection 
system to a universal protein detection system
103
. Specifically, a universal adapter was 
first created by conjugating a linear DNA strand with an Ezz protein domain. The 
universal adapter can interface between IgG antibodies and DNA dendrimer-based 
reporters. The IgG antibody detects specific antigen, while the DNA dendrimer 
reporter reveals the detection signal. As a demonstration of the capability, multiple 
proteins were detected with labeled dendrimer DNA reporters, including fluorescent 
dyes, quantum dots and horseradish peroxidase enzyme. This universal protein 
detection system permits multiplexed protein detection with multiple reporters, further 
revealing the modularity and high capacity of the DL-DNA. 
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Multifunctional dendrimers are powerful materials for real-world applications, 
because they can build different functional moieties into a single entity
104
. However, it 
is extremely complicated and difficult to synthesize anisotropic dendrider structure to 
achieve multi-functions
104
. Branched DNA can easily overcome this limitation by 
virtue of simply designing different sticky ends to each DNA branch. In light of this, 
we created an anisotropic branched crosslinkable (ABC) monomer by using the 
anisotropicity of branched DNA
97
. The ABC monomer was prepared by linking Y-
DNA with different functional moieties (modules) to the core X-DNA (Figure 1.9). 
The modules can be tracers (fluorescent dyes, quantum dots or gold nanoparticles), 
sensors (ssDNA molecular probes), effectors (therapeutic small interfering RNA, 
siRNA, or small molecular drugs) or chemical linkers (photocrosslinkable groups). As 
formed ABC monomer possess multi-functions including pathogen detection, 
multiplexed drug delivery and therapy. For instance, when the sensor module was 
designed into the ABC monomer, it served as a detection platform. In the presence of 
target pathogen DNA, two ABC monomers with the complementary sensing 
sequences were brought together, initiating the photopolymerization under UV light. 
This pathogen-driven polymerization was used to detect SARS, Ebola and Anthrax 
simultaneously
97
. On the hand, when the effector module was designed into the ABC 
monomer, it served as a multiplexed drug delivery platform
105
. Other applications 
such as imaging can be achieved if imaging reagents such as quantum dots, 
fluorescent dyes or carbon nanotubes is introduced into the anisotropic structure. 
These results indicated that the capability and versatility of branched DNA structure 
for real-world applications.  
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 In addition to diagnostics, the branched DNA structure has been successfully 
employed to enhance the therapeutic effect of DNA drugs
99, 100
. Similar to the gene 
sequence that encodes protein information, some special DNA sequences can encode 
immunological information. For example, CpG motif with the sequence of 5’-
GACGTT-3’ has immunostimulatory effects106-109, while other sequence motif such as 
5’-TTAGGG-3’ has immunosuppressive therapeutic potentials110-112. Thus, the DNA 
molecule itself can be used as an immune-modulator for DNA vaccine and DNA 
drugs. However, the potency of linear DNA is very limited. Takakura, Nishikawa and 
co-workers
99
 has designed to CpG motif into the DL-DNA structure to enhance its 
potency. Their results showed that much higher immune response was triggered 
compared to the linear DNA with the same dose of CpG motif, suggesting that the 
DL-DNA structure contributed to the immunostimulatory enhancement. Other motifs 
such as 5’-TTAGGG-3’ which has immunosuppressive function can also be imaged to 
be designed into the DL-DNA to create novel DNA drugs with higher potency against 
autoimmune disease such as multiple sclerosis and inflammatory arthritis. 
Since DNA can be easily degraded by nuclease, it can also be used as a 
sacrificial template to assist the synthesis of other functional materials. In light of this 
property, Lu and coworker created novel enzyme nanocomplexes with superior 
catalytic efficiency
113
. Exemplified by the synthesis of a triple-enzyme nanocomplex, 
the inhibitors of these three enzymes were first conjugated to different branches of X-
DNA. Those three different enzymes were then mixed with the X-DNA to form the 
triple-enzyme complex. Subsequent in situ polymerization led to the formation of a 
polymer shell around the enzyme complex. Finally, remover of the X-DNA-inhibitor 
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scaffold by nucleases resulted in a highly robust enzyme complexes colocalized in a 
polymer shell (Figure 1.10). Such a close proximity of those enzymes enabled active 
transport of the reaction intermediates among the enzymes, leading to significantly 
enhanced catalytic efficiency. In addition, encapsulating those enzymes within the 
polymer shell effectively stabilized them in a non-physiological environment and 
protected them against protease degradation. Furthermore, the polymer shell can be 
easily modified to introduce other functions such as desired surface properties and 
targeting capability
113
. Interestingly, the enzyme complex containing alcohol oxidase 
and catalase effectively reduced blood alcohol levels in intoxicated mice, creating a 
novel antidote and prophylactic for alcohol intoxication.  
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Figure 1.7. Schematic illustration of dendrimer-like DNA formation. Three partially 
complementary ssDNA (Ya, Yb & Yc) recognized and hybridized with each other to 
form the Y-shaped DNA (G0). By designing the sticky ends at the core G0 to be non-
palindromic, peripheral Y-DNA was added to the core in a controlled fashion to form 
the dendrimer-DNA (G1), through DNA hybridization and ligation. In a similar 
manner, higher generations of dendrimer-DNA were obtained.
92
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Figure 1.8. DNA barcode for multiplexed pathogen detection. The nanobarcodes with 
different detection probes were decoded based on the ratio of fluorescence intensity (a, 
G = green and R = red). Multiple target detection (a total of four targets) was achieved 
using nanobarcodes and microbeads (b, scale bar, 5 µm).
96
  
 
 23 
 
Figure 1.9. Schematic illustration of target-driven polymerization for pathogen 
detection. Different functional moieties were introduced to the Y-DNA, which 
included pathogen target DNA, corsslinkable group and quantum dots. These Y-DNAs 
were linked to the specific arms of X-DNA through pre-designed sticky ends, to form 
the anisotropic branched crosslinkable (ABC) monomer. In the presence of pathogen 
DNA, two ABC monomers were brought together by the DNA hybridization. The 
hybridized DNA was then photopolymerized in UV light to form aggregates, which 
enabled multiplexed pathogen detection.
97
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Figure 1.10. Schematic illustration of the synthesis of a triple-enzyme complex. 
Spontaneous assembly of invertase (A), glucose oxidase (B) and horseradish 
peroxidase (C) with an inhibitor-DNA scaffold containing their respective competitive 
inhibitors, lactobionic acid (a), glucosamine (b) and 4-dimethylaminoantipyrine (c), 
leading to the formation of a X-DNA triple-enzyme structure (I). in situ 
polymerization resulted a thin polymer shell around the enzyme complex (II). 
Removal of the DNA scaffold by nucleases leading to the formation of triple-enzyme 
complexes with significantly enhanced stability and catalytic activity.
113
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1.4 Networked DNA-based bulk materials and their applications 
Hydrogel is inherently a bulk-scale material, which has tremendous biomedical 
applications including drug delivery
114-120
, cell encapsulation
120-124
, 3-D cell culture
123-
126
 and tissue engineering
114, 124, 125, 127-137
. DNA, a superb naturally born 
biocompatible and biodegradable biomaterial, however, had limited demonstrations in 
these promising applications. The main hurdle is the challenge of synthesizing DNA 
materials in bulk-scale.  
Toward that end, our group pioneered in extending the 2-D branched DNA 
topology to create a 3-D networked DNA hydrogel
138
. By using branched DNA (X-
shaped, T-shaped, and Y-shaped DNA), we demonstrated a bulk-scale hydrogel 
entirely from DNA for the first time. The branched DNA were designed to have the 
palindromic sticky ends, thus allowing them to self-hybridize and ligate with each 
other to form a networked structure (Figure 1.11). Unlike conventional hydrogels, the 
DNA hydrogel gelation process was catalyzed by an enzyme, T4 ligase, which 
functions in neutral pH, room temperature, physiological relevant salt condition and 
aqueous environment. This offers the advantage of in situ encapsulating of drugs 
including small molecule drugs and therapeutic proteins, as well as live mammalian 
cells, eliminating the drug-loading step and also avoiding denaturing conditions. 
Indeed, without any loading step, we have demonstrated that the DNA hydrogel can 
successfully encapsulate and culture both Chinese hamster ovarian cells (adherent 
cells) and Hela S3 cells (floating cells). In addition, since the DNA hydrogel can be 
degraded by nucleases, it allowed the release of the encapsulated cells/drugs. 
Moreover, by simply changing the types and concentrations of the branched DNA, the 
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physical properties such as the modulus and pore size can be easily tuned. 
In addition to biomedical applications, the DNA hydrogel has also used in 
fabricating supercapacitors for energy storage
139
, as well as synthesizing ultrasmall 
AuNP for catalytic applications
140
. DNA is a naturally occurred polyelectrolyte, which 
has a negative charge due to the deionization of the phosphate group in the DNA 
backbone. By taking advantage of this property, Kim and coworkers prepared a 
capacitor by depositing other polyelectrolyte on top of the DNA hydrogel substrate
139
. 
Since the DNA hydrogel was formed in the physiological relevant conditions, it 
enabled the device to utilize physiological fluids as a source of electrolyte, allowing 
the device to be potentially implanted inside fluid rich organs such as blood vessel and 
bladder. On the other hand, Murata and coworkers concentrated Au precursors inside 
the DNA hydrogel, due to the high affinity of DNA base to transition metals
141, 142
. 
Further reduction of Au
3+
 yielded well dispersed, uniformly distributed and non-
aggregated AuNP of 2-3 nm size
140
. Such small AuNP is usually unstable due to the 
large surface area; however, the DNA hydrogel provides an excellent matrix to 
prevent the AuNP aggregation. As formed AuNP-DNA hydrogel hybrid showed 
superior catalytic activity in hydrogenation reaction of nitrophenol to aminophenol.  
Instead of using enzyme to chemically crosslink DNA together, Liu and co-
workers created another DNA hydrogel based on DNA molecular recognition
143
. 
Rather than designing palindromic sticky ends to the Y-DNA structure, they 
introduced i-motif, a cytosine-rich sequence, to the end of Y-DNA. At high pH values 
(pH > 8), the i-motifs are unprotonated, resulting the Y-DNA to electrostatically repel 
each other. When the pH value is adjusted to slightly acidic, the i-motifs become 
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partially protonated, which lead to the formation of hydrogen bond between 
protonated and unprotonated cytosines
144
. As formed hydrogen bond will cause the 
interlocking of the i-motifs among Y-DNAs and result the formation of a DNA 
hydrogel within minutes (Figure 1.12). The fast transformation of the i-motifs enables 
the DNA hydrogel to quickly release cargos such as gold nanoparticles upon the 
change of the environmental pH. More recently, they have developed another type of 
DNA hydrogel with thermal and enzymatic responsiveness from pure DNA self-
assembly
145
. In this design, they produced Y-DNA with 8 bp non-palindromic sticky 
ends, and a dsDNA linker with 8 bp complementary sticky ends. When the Y-DNA 
was mixed with the dsDNA, they spontaneously assembled into a networked structure 
to form a hydrogel. Since the hydrogel is not covalently crosslinked, it can transit from 
a gel state to a sol state when the temperature is above the melting temperature of the 8 
bp sticky ends. Indeed, they demonstrated that the gel switched between gel and sol 
state when changing the temperature from 25 to 50 °C, and this process was cycled 
many times. More interestingly, by designing enzymatic cutting site into the dsDNA 
linker, the hydrogel was also responsive to enzymatic manipulation, exhibiting a gel-
sol transition.  
 The responsive feature of the DNA hydrogel to exploited as a smart material to 
envelop and release single cells
146
. Trapping and sealing single cells in microwells are 
very useful to generate cell array for single cell analysis. Traditional sealing materials 
such as glass
147
 and polydimethylsiloxane (PDMS)
148
 fail to provide a permeable 
environment for media and oxygen, thus causing negative influence on cell behavior 
such as cell death. Liu and coworkers utilized the enzymatic responsive DNA 
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hydrogel to successfully seal and release the cells
146
. The cells were trapped in the 
microwells. Upon addition of the Y-DNA and the dsDNA linker, a hydrogel was 
formed spontaneously to seal the microwells. Due to the porous structure of the DNA 
hydrogel, the cover was permeable leading to a high survival rate of cells enveloped. 
Interestingly, the hydrogel cover can be opened by a restriction enzyme to cleave the 
DNA hydrogel, releasing cells on demand.  
In a similar fashion to the aforementioned branched-DNA, the DNA hydrogel 
can also be engineered to contain the immunostimulatory sequence and encapsulate 
doxorubicin, which functioned as a sustained delivery system for both 
immunostimulatory CpG motifs and intercalated doxorubicin for cancer treatment
100
. 
More recently, the molecular recognition properties of the DNA has been used to 
prepare an injectable, self-gelling, biodegradable and immunomodulatory DNA 
hydrogel for antigen delivery
149
. The branched-DNA monomers were injected to the 
mice, and gelation occurred instantaneously following injection at the physiological 
condition. The in situ formed DNA hydrogel can efficiently deliver tumor antigens 
with higher potency and less toxicity than clinically available vaccine adjuvants.  
 Besides using DNA as a generic material for diagnostics and therapeutics, we 
also took advantage of DNA’s genetic function, which cannot be achieved by any 
other material, to create the first ever cell-free protein producing gel (P-gel, Figure 
1.13)
150
. The P-gel was composed of X-DNA and linearized plasmids, which were 
covalently ligated together by T4 ligase. The X-DNA served as the scaffold, while the 
plasmid functioned for protein production. After incubating with the 
transcription/translation-related enzymes, amino acids, and ATPs, P-gel produced 
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proteins in a cell-free environment with an up to 300 fold increase than the current 
solution-based systems. Such enhanced efficiency was due to fact that the bulk-scale 
DNA hydrogel format can improve the gene stability, increase local gene 
concentration and enzyme turnover rate as a result of the closer proximity of genes. 
Since the P-gel can produce protein in a cell-free fashion, it can generate a greater 
number of proteins including toxic and membrane proteins than the conventional cell-
based protein expression system. The gel-based protein production platform revealed 
that the complicated transcription and translation processes can be replicated outside 
the cells in a gel network, indicating that the P-gel can serve as a general protein 
production technology.  
Even though temperature can be used to change the gel state from gel to sol, 
however, sometimes intact branched DNA structure is desirable at high temperatures, 
such as PCR. Toward that end, we designed a thermostable branched DNA 
structure
151
, by using psoralen, a naturally occurring reagent that intercalates and 
cross-links DNA
152
. The psoralen-crosslinked branched DNA structure can withstand 
denaturing conditions without disruption of their integrity. Thus, the thermostable 
branched DNA was successfully utilized as primers for PCR, enabling high 
temperature multiplexed detection. Moreover, by using GFP gene as the PCR 
template, the gene sequence was amplified and incorporated into the thermostable 
branched DNA structure to form a protein producing gel. Due to the generality of 
psoralen crosslinking, this thermostable concept can also be extended to all other DNA 
based structure.   
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Figure 1.11. Formation of bulk-scale DNA hydrogel. X-DNA with palindromic sticky 
ends were linked together by the T4 ligase to form the DNA hydrogel (a). Photographs 
of DNA hydrogel patterned into CORNELL shapes (scale bar is 1 cm and 500 um for 
the top and bottom images, respectively (b). The bottom gel was stained with a DNA-
specific fluorescent dye: SYBR I).
138
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Figure 1.12. Principle structure of the pH-responsive DNA gel. a) A Y-shaped DNA 
nanostructure with three free interlocking domains (Y unit); b) enlargement of the 
circled region in (c) to show the formation of inter-Y-unit i motif: two black domains 
from neighboring DNA Y units form an i motif to cross-link adjacent Y units; c) DNA 
hydrogel made from the three-dimensional assembly of DNA Y units. The sequences 
(with different domains in different colors) of the three DNA strands used in the 
assembly. Gel transition switched by pH change (visualized with GNPs. a) 7 nM 
GNPs were trapped in DNA hydrogel (40 μL) with a covering layer of 50 mM MES 
buffer (pH 5.0, 50 mM NaCl). b) After the pH value of the buffer had been changed to 
pH 8.0, the GNPs were released from the DNA hydrogel to form a uniform solution. 
c) Time trace of the absorption at 520 nm for the upper part of the solution before and 
after addition of NaOH.
143
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Figure 1.13. Formation of DNA-based, cell-free protein producing gel (P-gel). X-
DNA were ligated with the plasmids to form the P-gel. After incubating the P-gel with 
the transcription and translation related reagents, such as lysate, polymerase, amino 
acid, ATP and so on, proteins were expressed with high efficiency from the P-gel. The 
blue color and green color indicated that functional proteins of luciferase and green 
fluorescent protein were produced from P-gel.
150
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1.5 Significance of this dissertation  
Even though extensive efforts has been made in bulk-scale DNA materials and 
their application, methods for creating bulk-scale DNA materials, especially DNA 
hydrogels, are still limited. All current methods for producing DNA hydrogels are 
based on the following processes: forming branched DNA structures and crosslinking 
them together either by ligation or hybridization. In this dissertation, I will introduce 
an entirely novel method to create a DNA hydrogel by physical entanglement for the 
first time. Instead of resorting to branched DNA, I utilize enzymatic amplifications to 
produce long ssDNAs, both in length and in quantity, and entangle them to form a 
DNA hydrogel. Due to the power of enzymatic amplification, a bulk-scale hydrogel is 
produced with low cost and readily to be scaled up. Interestingly, the hydrogel consists 
of uniformly sized DNA microspheres. Those microspheres can be easily isolated 
from the hydrogel, and to our surprise, the DNA density in each microsphere reaches 
as high as the human chromosome density in the metaphase. Such high DNA density 
enables the DNA microsphere to concentrate unprecedentedly high dose DNA drugs 
that have never been achieved. This super-condensed ultra-high dose DNA 
(scudDNA) effectively protects the condensed DNA, efficiently enters the cell and 
releases the DNA, resulting a superior therapeutic effect.  
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CHAPTER 2: SYNTHESIS AND CHARACTERIZATION OF A PHYSICALLY 
ENTANGLED DNA HYDROGEL 
 
2.1 Introduction 
DNA hydrogel has shown tremendous potential in biomedical applications. 
However, the method of synthesizing DNA hydrogel is very limited. From the 
hydrogel structure perspective, it can be classified into two categories, chemical gel in 
which the crosslinking points are linked with each other, and physical gel in which the 
crosslinking points are entangled with each other. All the current methods for 
producing DNA hydrogels are based on linking the branched DNA structures, either 
by ligating them
138
 or hybridizing them
143, 145
 to form a chemical DNA gel. Therefore, 
developing a novel method to create physically entangled DNA hydrogel can greatly 
expand the DNA hydrogel reservoir.  
To do so, we designed a totally different approach: instead of using branched 
DNA structures, we elongated linear DNA chains and “wove” them non-covalently 
into a physical hydrogel via a polymerase. To fabricate the physical DNA hydrogel, 
we chose a special polymerase: Φ29, a bacteria phage polymerase that was capable of 
DNA chain elongation and chain displacement, thus amplifying and weaving DNA. 
Φ29 used a single-stranded DNA (ssDNA) as a template to elongate the primer while 
at the same time displacing the newly synthesized strands into ssDNA products. Based 
on Φ29, we designed a unique combination of two sequential processes: (i) a Rolling 
Circle Amplification (RCA, or R) followed by (ii) a Multi-primed Chain 
Amplification (MCA, or M).  
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In more detail, Primer-1 was first hybridized to a circular DNA template. In 
the presence of Φ29, Primer-1 was elongated using the circular DNA as a template 
(Figure 2.1). After running the RCA for x hours (hrs), a long ssDNA-1 was generated 
with the tandem repeats of the circular DNA template sequence. Then excess amount 
(1000 fold of Primer-1) of Primer-2 and Primer-3 were introduced to the solution to 
initiate the MCA. Primer-2 had the complementary sequence to the ssDNA-1, while 
Primer-3 had the same sequence of ssDNA-1. First, a number of Primer-2 was 
periodically hybridized to the ssDNA-1 and elongated using ssDNA-1 as a template. 
During this process, old strands, which were previously produced on same ssDNA-1, 
were displaced by the advancing new strand. This newly displaced ssDNA became a 
new template, ssDNA-2. Then a number of Primer-3 was hybridized to ssDNA-2. In a 
similar fashion, Primer-3 was elongated and displaced by the polymerase to generate 
ssDNA-3. Since ssDNA-3 possessed the same sequence repeats as ssDNA-1, it can be 
utilized as a template for Primer-1 again. Thus, a chain reaction was established and 
large amounts of ssDNA-1 and ssDNA-2 were generated. Since the RCA and MCA 
products were very long (greater than 46 milliion Da
153
), and since the produced 
ssDNA-1 was complementary to ssDNA-2, these long and linear DNA chains would 
entangle together as well as hybridize to each other at multiple points, resulting in 
entangling the whole system into a gel-state
154
 (Figure 2.1). To the best of our 
knowledge, this is the first time that a DNA hydrogel is synthesized by physical 
entanglement, and from a pure enzymatic amplification process.  
Interestingly, our DNA hydrogel had properties that were not found in nature 
of any kind: it had both solid-like and liquid-like properties. When the gel was 
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immersed in water, it memorized its original shape and behaved like a solid. However, 
the hydrogel became free-flowing “liquid” when taken out of water, and went back to 
its original shape upon re-introducing water. The whole process of gel-to-liquid 
transition can be repeated many times and were triggered by simply adding or 
removing water. The unusual properties were further examined by the unique internal 
structure of the hydrogel, as well as the mechanical stresses applied to the hydrogel. 
As a potential application for the liquid-like and solid-like behavior, we utilized the 
hydrogel to create an electric circuit that used water as a switch. 
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Figure 2.1. Schematic diagram of step-wise approach for the physically entangled 
DNA hydrogel synthesis. The RCA and MCA processes were carried out as follows. (i) 
For the R-process: a circular ssDNA template was first produced and then a 
complementary primer for RCA (Primer-1) was added, which produced elongated 
ssDNA products (termed as ssDNA-1: tandem repeats of the sequences that was 
complementary to the original circular ssDNA template). (ii) For the M-process: after 
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RCA we added two additional primers (Primers-2 and Primer-3) for subsequent chain 
amplification: Primer-2 was elongated to generate ssDNA-2 (which was 
complimentary to ssDNA-1); Primer-3 was used to create ssDNA-3 (which was 
complementary to ssDNA-2, thus ssDNA-3 and ssDNA-1 had the exact same 
sequences). As a result, Primer-2 was also able to produce more ssDNA-2 using newly 
synthesized ssDNA-3 as templates, leading to the chain amplification.
154
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2.2 Materials and Methods 
2.2.1 Chemicals and DNA sequences 
Φ29 DNA polymerase, Exonuclease I and Exonuclease III were purchased 
from New England Biolabs (Beverly, MA). CircLigase
TM
 ssDNA Ligase was 
purchased from Epicentre Biotechnologies (Madison, WI). Oligonucleotides were 
commercially synthesized and PAGE purified (Integrated DNA Technologies, 
Coralville, Iowa).  Sequences of the oligonucleotides are listed in Table 2.1. 
2.2.2 Preparation of circular DNA templates 
Phosphorylated linear ssDNA template (0.5 µM) was treated with of 
CircLigase
TM
 ssDNA Ligase (5 unit/µl) overnight at 65 ºC in 200 µL of reaction 
buffer (50 µM of ATP, 2.5 mM of MnCl2) to circularize the linear DNA. The ligase 
was then inactivated by incubating the reaction solution at 80 ºC for 10 min. To 
remove the non-circularized linear ssDNA template, excess amount of exonucleases 
(i.e. 300 U of Exonuclease I and 3,000 U of Exonuclease III) were added to the 
solution. This solution was then incubated at 37 ºC for 3 hrs and denatured at 80 ºC for 
40 min to inactivate the exonucleases. YM-10 (10 000 Da molecular weight cutoff) 
columns were used to purify and concentration the circularized DNA. The formation 
and purity of the circularized DNA template was examined by 10 % denatured 
polyacrylamide gel electrophoresis (PAGE) at 600 V at 25 °C for 1 hour with Tris-
borate-EDTA buffer (TBE, pH 8.3). The PAGE was stained by SYBR II (Molecular 
Probes, USA) following the manufacturer’s protocol. 
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2.2.3 Synthesis of DNA hydrogel by DNA polymerization 
The circular DNA template was first hybridized with Primer-1 at room 
temperature for 2 hrs by incubating an equal molar amount of them in TE buffer (pH 
8.0, 10mM Tris, 1mM EDTA). Hybridized circular DNA templates (50 nM) were 
incubated with Φ29 DNA polymerase (1 unit/µl) at 30 °C for x hrs in 100 l of the 
reaction buffer (50mM Tris-HCl, 10mM (NH4)2SO4, 10 mM MgCl2, 4 mM 
dithiothreitol, 200 µg/ml bovin serum albumin and 10 - 50 mM dNTP). Primer-2 and 
Primer-3 (50 M of each) were then added into the reaction solution to initiate the 
multi-primed chain reaction y hrs at 30 °C without adding additional reagents. 
2.2.4 Characterization of the DNA hydrogel 
a. Gel formation process monitoring 
The solution for DNA polymerization was first prepared in a 96-well plate 
without Φ29 DNA polymerase. After Φ29 DNA polymerase was added, optical 
density (OD) at 600 nm was evaluated by a microplate reader (BioTek Synergy4 Plate 
Reader, BioTek Instruments, Inc., Winooski, Vermont) every hour at 30 °C for a total 
duration of 20 hrs. 
b. Staining of the DNA hydrogel 
The formed DNA hydrogel was stained with GelGreen, a green fluorescent 
nucleic acid dye designed to stain both dsDNA and ssDNA, at 4 
o
C overnight. The 
stained gel was imaged under UV light at 254 nm.   
c. Rheology Test of the DNA hydrogel 
A Rheometric Scientific Inc. (RSI) rheometer with parallel cone and plate 
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fixtures was used to measure the mechanical properties of the DNA hydrogel. 200 l 
DNA hydrogel was sandwiched between the cone and plate. A dynamic frequency 
sweeping mode (from 0.1 to 100 rad/s) was used, with the strain fixed at 50%. The 
storage modulus and loss modulus of the DNA hydrogel were recorded in real time.  
d. Scanning Electron Microscope (SEM) imaging 
 Zeiss Ultra SEM (Carl Zeiss Inc., Germany) was used to obtain high resolution 
images of the DNA hydrogel. The DNA hydrogel was placed onto the top of the SEM 
holder and air dried. The sample was metal-coated with Au/Pd.  
e. Focused-Ion Beam 
 FEI Strata 400 STEM FIB (FEI Company, USA) was used to cut individual 
DNA microsphere. The DNA microsphere was isolated from the DNA hydrogel and 
placed onto the top of SEM holder. The sample was metal-coated with Au/Pd. After 
cutting, the internal structure of the DNA microsphere was observed using SEM.  
f. Electrical Property Measurement 
To test the capability of DNA hydrogel as an electric circuit switch, gel was 
first formed in a mold. Gold nanoparticles of 10 nm were doped into the gel during the 
gelation. The current vs voltage curves were measured using a Keithley 6430 
(Keithley Instruments, Inc., USA), both before or after adding water to the DNA 
hydrogel.  
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2.3 Results and Discussions 
2.3.1 Fabrication of the circularized DNA template 
Linear ssDNA before and after circularization was run in 10% denature PAGE 
gel. A clear band shift was observed for the circularized DNA compared to the linear 
DNA (Figure 2.2), indicating the successful formation of the circular DNA template. 
The lower mobility of the circular DNA in the PAGE gel was due to the loss of its free 
ends after the circularization
155
. In addition, no leftover of linear DNA was presented 
in the circularized DNA sample, suggesting that the exonucleases had totally removed 
the unreacted linear DNA template. We emphasized that the purity of the circular 
DNA template was critical to the DNA hydrogel formation.  
2.3.2 Formation of the DNA hydrogel  
The enzymatic processes were monitored by the optical density (OD) at 600 
nm. For example, when R-process was fixed at 4 hrs, the OD increased with the 
duration of M-process (Figure 2.3). After M-process reached 16 hrs (i.e., R4M16), a 
totally opaque hydrogel was formed (Figure 2.3). On the other hand, R-process itself 
for as long as 20 hrs (R20M0) only produced a viscous solution (Figure 2.3). Moreover, 
there was no detectable signal for R20M0 solution in the rheometer, proving that 
R20M0 was just a liquid. We further examined the gel formation by varying the time 
combinations of x and y and found that a minimum of x = 2 hrs and y = 16 hrs was 
required in order to create a DNA hydrogel (Table 2.2). These results indicated that 
both RCA process, which produced long DNA chains, and MCA process, which 
initiated chain reaction and generated many long DNA chains, were needed in order to 
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form a physically entangled DNA hydrogel. 
The opaque solution formed at R4M16 reaction was confirmed to be a 
hydrogel, as it maintained its tube shape when immersed in water (Figure 2.4a). We 
noted that the size of the hydrogel was easily produced at centimeter scale and can be 
readily scaled up. As expected, this hydrogel emitted green fluorescence after staining 
with a DNA-specific dye GelGreen (Figure 2.4b), indicating that the entire hydrogel 
was composed of DNA. Rheology data further confirmed that the R4M16 was a true 
gel since the shear-storage modulus (G’, representing the elasticity) was constantly 
higher than the shear-loss modulus (G’’, representing the viscosity) over the entire 
frequency range (Figure 2.4c).  
 
Figure 2.2. Gel electrophoresis image of linear and circular DNA template. Lane 2 
indicated circular template DNA which showed slower mobility than linear DNA 
(Lane 1) after circularization.
154
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Figure 2.3. Monitoring the gel formation by optical density. OD of only RCA up to 20 
h without MCA (●, Rx) and 4 h RCA with MCA up to 16 h (●, R4My) were measured 
at a wavelength of 600 nm. Photographs of the cuvette containing R4M1, R4M3, R4M6, 
and R4M16 showed clear visual changes of the gel going from transparent to opaque. 
However, Rx remained transparent up to 20 h.
154
  
 
 
 
 45 
 
 
Figure 2.4. Characterization of the R4M16 DNA hydrogel. a. Photograph of R4M16 
hydrogel. The scale bar is 10 mm. b. Stained hydrogels with GelGreen, a DNA 
specific dye. c. Storage (G’) and shear loss (G’’) modulus of R4M16 hydrogel from a 
Rheometer measurement.
154
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2.3.3 Unique internal structures of the DNA hydrogel 
Unlike conventional hydrogels, whose internal structures are amphorous
138, 150, 
156
, our R4M16 hydrogel had strikingly unique hierarchical internal structures, 
indicated by the field emission scanning electron microscopy (FE-SEM). At the 
micro-scale, DNA microspheres were densely packed in the hydrogel (Figure 2.5a). 
These unique microspheres had uniform size (1.6 μm ± 0.2 μm) and wove together by 
DNA. Within each microsphere, internal porous nanostructures were observed by 
cutting the DNA microsphere into half via focused ion beam (Figure 2.5 b-c). To the 
best of our knowledge, this type of hierarchical structure has never been seen before in 
conventional hydrogel, and may contribute to its unique properties.  
We further selectively tuned the hierarchical structures by simply changing the 
reaction time of R and M separately. More specifically, by elongating the R-process 
from 0 hrs to 8 hrs, while keeping the M-process constant at 16 hrs (i.e., R0M16, 
R1M16, R2M16, R4M16 and R8M16), we obtained denser populated DNA microsphere 
with almost identical size (Figure 2.5 d-h, from 10 ± 2/100 µm
2
 in R0M16 to 35 ± 
5/100 µm
2
 in R8M16). On the other hand, by increasing the M-process reaction time 
from 1 hr to 16 hrs, while keeping R-process constant at 4 hrs (i.e., R4M1, R4M3, 
R4M6, and R4M16), we produced a more developed DNA microspheres (Figure 2.6 a-
d). The diameter of the DNA microsphere increased from ~ 0.3 μm in R4M1 to ~ 1.6 
μm in R4M16. We emphasize that these differently tuned hierarchical internal 
structures were easily accomplished by designing and controlling the enzymatic 
reactions of RxMy.  
 47 
 
Figure 2.5. Morphology of the DNA hydrogel with different RCA-process time. a, 
SEM images of R4M16 DNA hydrogel. b,c, SEM images of an individual microsphere 
that was isolated (b), and cut with focused ion beam (c). d-h, SEM images for 
different RCA time: R0M16 (d), R1M16 (e),  R2M16 (f), R4M16 (g) and R8M16 (h).
154
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Figure 2.6: Morphology of the DNA hydrogel with different MCA-process time. a, 
R4M1, b, R4M3, c, R4M6, d, R4M16. Scale bars in insets, 200nm. Not only the number 
of the DNA microsphere were increasing, but also the diameters of DNA microsphere 
were growing from 350 ± 80nm for R4M1, 550 ± 100nm for R4M3, 790 ± 150nm for 
R4M6 and  1600 ± 200nm for R4M16.
154
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2.3.4 Unusual mechanical properties of the DNA hydrogel 
Unexpectedly, we discovered unusual mechanical properties of our DNA 
hydrogel that were not found in nature: it had both liquid-like and solid-like properties. 
When the gel was taken out of water, it became a “liquid” and flew freely in the tube 
(Figure 2.7a), and conformed to the shape of its container, such as star-shape, circle-
shape, rectangle-shape, triangle-shape and cross-shape (Figure 2.7b). However, when 
the gel was put back into water, it metamorphosed into a solid gel. Surprisingly, the 
gel always returned to its birth shape in water, regardless of how many different 
shapes it had taken in the liquid-like state. To further investigate this unusual property, 
we first formed R4M16 hydrogel in molds with defined geometries in the shape of the 
English letters “D”, “N” and “A” (Figure 2.7c). After removing water, each hydrogel 
behaved like a liquid by conforming to the shape of the vial (Figure 2.7d). However, 
when the water was reintroduced, the hydrogels returned to their birth shapes (“D”, 
“N”, and “A”, Figure 2.7e). This shape transition of the gel was monitored in real time 
(Figure 2.7f). When the water is introduced, the gel started to metamorphose within 
the first 3 s (from t = 0 s to 3 s). The gel continued to transform back to its birth shape 
gradually and smoothly (from t = 3 s to 9 s). The final shape of “D” was restored 
within 15 s (t = 15 s). These liquid-to-solid transition and returning-to-original-shape 
processes can be repeated as many times as one likes. These results clearly 
demonstrated the unprecedented DNA hydrogel with unusual mechanical properties 
that have never been created before. 
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Figure 2.7. Liquid-like and Solid-like property of R4M16 hydrogel. a, When out of 
water, the hydrogel flowed freely in the tube. b, When the hydrogel was poured into 
different shaped-containers consecutively and repeatedly (from circular to square to 
triangular to X-shaped to star-shaped and back to circular), it conformed to the shape 
of its container, just like a liquid. The gel was stained with GelGreen. c, “D”, “N”, and 
“A”-shaped hydrogel are successfully formed and tested its solid-like property by 
removing and replacing water. d, Series of photographs showing the process of DNA 
hydrogel going back to the birth shape after reintroducing water at 25 °C: the gels 
started to metamorphose within the first 3 s (from t = 0 s to 3 s). The gel continued to 
transform back to its birth shape gradually and smoothly (from t = 3 s to 9 s). The final 
shape of “D” was restored within 15 s (t = 15 s).154  
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2.3.5 Mechanism for the unusual mechanical properties  
To understand the mechanism for this unusual mechanical behavior, we 
carefully analyzed the stresses applied to the gel. There are two stresses involved in 
deforming a hydrogel when the gel is placed in the air. They are surface tension stress 
L and gravitational stress rgL . On the other hand, elastic stress E of the hydrogel 
resists the deformation. Here,is the surface tension, L is the length scale of the gel, 
r  is the specific gravity of the gel, g is the gravitational constant, is magnitude of 
the strain and E is the Young’s modulus. For a hydrogel with the length scale of 1 cm, 
the surface tension is 7.2 N/m
2
 and the gravitational stress is 98 N/m
2
. Here we use  = 
0.072 N/m, r =1000  kg/m3 and g = 9.8 m/s2.  
For most hydrogel, the elastic modulus is in the range of KPa to MPa
138, 145, 157
. 
The strain induced by the surface tension and gravity is negligible, thus the gel 
supports itself and keeps its original shape when it is in the air. However, for our DNA 
hydrogel, the elastic modulus is as low as 5 Pa (Figure 2.4). The surface tension and 
gravity is able to deform the hydrogel as much as 21 times. If our hydrogel is elastic 
and is not damaged by those two stresses, it will behave like a liquid. To test the 
elasticity of the hydrogel, we anchored the gel between two clippers with the initial 
length of 3 mm. By gradually stretching the two clippers apart from each other, the gel 
was elongated to as much as 51 mm without breaking (Figure 2.8). Because of the 
high elasticity and the low elastic modulus of the hydrogel, it possessed the unusual 
mechanical properties.  
Chemically, the DNA hydrogel was composed of DNA chains (both ssDNA 
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and dsDNA) and physically entangled crosslinking points. This specific molecular 
structure endowed the hydrogel with very low modulus (~5 Pa). When the hydrogel 
was in water, it exhibited solid-like property. After water was removed from the 
chamber, the hydrogel was exposed to air. Because the hydrogel was extremely elastic, 
it could not keep its shape under the surface tension and gravitational stresses, thus it 
was deformed at the water/air interface. After all the water was totally removed from 
the chamber, under the stresses of surface tension and gravity, the gel conformed to 
the shape of the chamber, resembling the property of water. After the hydrogel was re-
immersed in the water, the gravity was canceled by the buoyance stress. Thus the gel 
restored to its original shape via elastic stress, exhibiting the solid-like property 
(Figure 2.9). 
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Figure 2.8. Elasticity of the DNA hydrogel. The DNA hydrogel (white color) was 
anchored between two clippers with the original length of 3 mm. After stretching the 
two clippers apart from each other, the gel was elongated to as much as 51 mm, 
representing a 17 fold deformation.  
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Figure 2.9. Schematic molecular mechanism of the liquid-like and solid-like properties 
of the DNA hydrogel. a, The DNA meta-hydrogel was composed of DNA chains (both 
ssDNA and dsDNA) and the entangled crosslinking points. This specific molecular 
structure endowed the hydrogel with very low modulus (~5 Pa). b, After water was 
removed from the chamber, the hydrogel was exposed to air. Because the hydrogel 
was extremely soft, it could not keep its shape under the surface tension and 
gravitational stress, thus it was deformed at the water/air interface. c, After all the 
water was totally removed from the chamber, under the action of surface tension and 
gravity, the gel conformed to the shape of the chamber, resembling the property of 
water. After reintroducing water into the chamber, the hydrogel returned to its birth 
shape, exhibiting the solid-like property.
154
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2.3.6 Applications of the unusual mechanical properties  
Many applications can be envisioned by using our DNA hydrogel. We first 
explored our hydrogel’s potential as a controlled drug release system. A unique 
advantage is that both the gel material building blocks (DNA) and the gel itself 
(physical enclosure) can be used as drug reservoirs. We loaded our DNA hydrogel 
with drugs, DOX and insulin, by chemical intercalation and physical entrapment, 
respectively. As expected, the physically entrapped drug had a much faster releasing 
profile than the chemically intercalated drug (Figure 2.10). This property can be 
potentially applied to the release of different drugs in a time-controlled fashion.  
In addition, applications can also take advantage of using either or both liquid-
like and solid-like properties of our hydrogel. As an example we designed a DNA-
hydrogel-based electric circuit which used water as a switch (Figure 2.11). When the 
surrounding water was removed, the DNA hydrogel (doped with 10 nm gold 
nanoparticle to attain electric conductivity) became “liquid-like” and thus conformed 
to the shape of the channel linking the two electrodes together. As a result, the circuit 
was turned on (Figure 2.11 “ON”). By simply adding water back to the meta-hydrogel, 
DNA hydrogel became “solid-like” and thus remembered its birth shape (which was 
shorter) actuating the gel to move away rapidly from the electrode and consequently 
shutting off the current completely (Figure 2.10, “OFF”).  
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Figure 2.10. Drug release profiles of R4M16 DNA hydrogel. Controlled drug release 
profiles with insulin (♦) and doxorubicin (●). The volume of the DNA hydrogel was 
70μl. 154 
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Figure 2.11. Electric circuit switches by using liquid-like and solid-like properties of 
DNA hydrogel. With liquid-like property of gel, the circuit can be covered by DNA 
gel encapsulating 10 nm AuNP (●, “On”). By simply adding water the gel 
metamorphosed to its birth shape which was shorter, resulting in the gel moving away 
rapidly (within seconds) from the electrode and consequently shutting off the current 
completely (▲, “off”). The scale bars of inset are 5mm.154 
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Table 2.1. Oligonucleotide sequences of linear ssDNA and primers for the DNA 
hydrogel. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strand Sequence 
Linear 
ssDNA 
5’-Phosphate-
TCGTTTGATGTTCCTAACGTACCAACGCACACGCAGTAT
TATGGACTGGTAAAAGCTTTCCGAGGTAGCCTGGAGCAT
AGAGGCATTGGCTG-3’ 
Primer1 
5’-TAGGAACATCAAACGACAGCCA-3’(complementary to 
TGGCTGTCGTTTGATGTTCCTA in circular template) 
Primer2 5’-ACGCAGTATTATGGACTG-3’ 
Primer3 
5’-TGGTACGTTAGGAACATC-3’(complementary to 
GATGTTCCTAACG TACCA in circular template) 
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Table 2.2. Influence of RCA and MCA process durations on the solid-like and liquid-
like properties of DNA hydrogel. 
 
*: These reactions resulted in turbid solutions with liquid-like properties (e.g. “flow”). 
However when they were transferred back into water, they did not maintain their 
original shapes. Thus we defined them not having solid-like property.
154
 
 
Gel type (RxMy) Solid-like property Liquid-like property 
R0M16* NO YES 
R1M16* NO YES 
R2M16 YES YES 
R4M16 YES YES 
R8M16 YES YES 
R12M16* NO YES 
R16M16* NO YES 
R4M1 NO YES 
R4M3 NO YES 
R4M6 NO YES 
R4M20 YES YES 
R4M24 YES YES 
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2.4 Conclusion 
We have successfully created a bulk-scale physically entangled DNA 
hydrogel based on pure enzymatic amplification for the first time. By designing two 
enzymatic processes, rolling circle amplification and multi-primed chain 
amplification, DNA chains are greatly amplified, both in length and in quantity, to 
entangle with each other to form a DNA hydrogel. Due to the amplification power of 
the enzymatic amplification, the hydrogel is synthesized at low cost and can be readily 
scaled up. Interestingly, our hydrogel possesses an internal hierarchical micro-
structure that gives rise to the unusual mechanical properties that have not been found 
in nature of any kind: it behaves like a liquid and flows freely when taken out of water, 
and becomes solid and goes back to its original shape when immersed in water. Our 
work will significantly expand DNA materials repertoire with great potential for real-
world applications, including drug release, cell therapy, protein expression, electric 
switch, flexible circuits, and others.  
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CHAPTER 3: BIOMEDICAL APPLICATIONS OF THE PHYSICALLY 
ENTANGLED DNA HYDROGELS * 
 
3.1 Introduction 
Modern drug discovery started in the early twentieth century with rational 
syntheses of small-molecule drugs and advanced 50 years later to large-molecule 
biologics via recombinant DNA technology and monoclonal antibody technology. 
Currently, nucleic acid (DNA and RNA) has been demonstrated as one of the most 
recent biologics for disease prevention and treatment, including nucleic acid 
diagnostics
97, 158, 159
, siRNA therapy
105, 160, 161
, gene therapy
162
 and DNA vaccines
163, 
164
. While most of these applications relied on the protein coding sequences, a special 
class of DNA that was composed of only non-coding, unmethylated CpG motifs was 
developed as a promising immunotherapy drug through the innate immune system
106, 
107, 165, 166
. The CpG motif specifically interacts with the toll-like receptor 9 (TLR9) 
presented in the endocytic vesicles after being endocytosed
167
. This specific 
interaction directly activates immunostimulatory cascades
165
 characterized by the 
elevated productions of proinflammatory cytokines including tumor necrosis factor 
alpha (TNF-) and interleukin 6 (IL-6)99, 168. As of now, more than a dozen of CpG-
based DNA drugs are in clinical trials as vaccine adjuvants, anti-allergens, and cancer 
immunotherapy drugs
108, 109, 169
. 
*: A paper based on this chapter has been submitted with the authors: Songming Peng, 
Chuangying Xu, Chunyan Li, Mark R. Hartman, Yan Yu, Wei Han, Qiangbin Wang 
and Dan Luo. 
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Even though promising, the lack of potency and fast degradation in vivo of 
DNA remain to be two important hurdles. To address the issue of inadequate potency, 
four different classes of CpG-containing DNA, each with distinct flanking sequences, 
were developed in order to elicit stronger immune responses
108
. To mitigate the 
degradation problem, instead of using natural DNA with phosphodiester bonds 
(poDNA), DNA backbones replaced by phosphorothioate bonds (psDNA) were 
employed
108
; psDNA was not a substrate of nucleases thus resisted the degradation. 
Fundamentally, both hurdles are related to the dose issue. If one can administer a 
much larger effective dose, in theory the efficacy will increase and degradation will 
have minimal impact. However, the therapeutic window limits how high the dose one 
can reach. In fact, this is also a general challenge for almost all drugs: how to 
formulate a very high effective dose without causing toxicities. 
Our physically entangled DNA hydrogel revealed a striking internal micro-
structure, a huge amount of uniformly sized DNA microspheres. Those microspheres 
can be easily isolated from the hydrogel with high yield, and to our surprise, we 
discovered that the DNA density in the microsphere reached as high as human 
chromosome density in the metaphase. Such high density might be able to serve as a 
great platform to condense high dose of DNA drugs, such as CpG motifs. Indeed, by 
designing CpG motif into the circular DNA template, we created a novel DNA 
structure termed as super-condensed, ultra-high dose DNA (scudDNA); the scudDNA 
was composed of over several million doses of CpG motifs (Figure 3.1a-d). 
Importantly, such an unprecedented high dose was super-condensed into only one 
single microsphere, serving as a self-releasing system without causing much toxicity. 
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Excitingly, scudDNA elicited enhanced cell immune responses in vitro and 
successfully suppressed tumor growth in vivo, while the same DNA with the same 
dose without scudDNA structure failed to do so (Figure 3.1e-g). To the best of our 
knowledge, this was the first time that millions of therapeutic CpG motifs were 
condensed into one microsphere and that the condensed structure itself served as an 
effective drug formulation. Our scudDNA structure can incorporate any past or future 
CpG sequences, or any other therapeutic sequences, providing a novel platform for all 
nucleic acid-based drugs.  
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Figure 3.1. Schematic illustration of the production and function of the scudDNA. a, 
The circular immune DNA template was designed to have two CpG motifs. Upon 
binding with primer 1, the rolling circle amplification was initiated by the Φ29 DNA 
polymerase to produce long DNA. b, After adding primer 2 and primer 3, multi-
primed chain reaction was initiated. The amplified long DNA chains, which contained 
large amounts of CpG motifs, were entangled to form a DNA hydrogel. c, The DNA 
hydrogel was immersed in water, and was composed of DNA microspheres 
(scudDNA) and DNA bundles. d, The scudDNA was isolated from the hydrogel by 
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mechanically breaking the DNA bundles. e, By incubating with macrophage cells, the 
scudDNA was effectively endocytosed. f, The scudDNA elicited enhanced 
immunostimulatory effects, characterized by the TNF- and IL-6 release, compared to 
the control shortDNA and PBS. g, Mice were inoculated with tumor cells, and after 
one week, injections of scudDNA were administered for three weeks at a frequency of 
twice a week. The tumor was retrieved at week five. The tumor size indicated that the 
scudDNA effectively suppressed the tumor growth, while the control shortDNA failed 
to do so. h-i, The microstructure of scudDNA in the hydrogel (h) and isolated 
scudDNA (i) was revealed by scanning electron microscopy.  
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3.2 Materials and Methods 
3.2.1 Chemicals, cells and animals 
Φ29 DNA polymerase was purchased from Epicentre Biotechnologies 
(Madison, WI). Inorganic pyrophosphatase was purchased from New England Biolabs 
(Beverly, MA). Oligonucleotides were commercially synthesized and PAGE purified 
(Integrated DNA Technologies, Coralville, Iowa). Sequences of the oligonucleotides 
are listed in Table 3.1. Enzyme-linked immunosorbent assay (ELISA) kits for TNF- 
and IL-6 detection were purchased from Syd Labs (Natick, MA). Mice macrophage 
cell line Raw 264.7 was purchased from American Type Culture Collection (ATCC, 
Manassas, VA). Mice colon tumor cancer cell line (CT26.WT) was obtained from 
Shanghai Cell Bank (Shanghai, China). 6-week-old female BALB/c mice were 
purchased from Shanghai SLRC Laboratory Animal Company (Shanghai, China). 
3.2.2 Super-condensed ultra-high dose DNA (scudDNA) fabrication  
Ligated circular immune DNA template (50 nM), which was hybridized with 
primer 1 (50 nM), was incubated with Φ29 DNA polymerase (1 unit/l) in the 
reaction buffer (40 mM Tris-HCl, 50 mM KCl, 10 mM MgCl2, 5 mM (NH4)2SO4, 4 
mM dithiothreitol, 200 g/ml bovin serum albumin and 10 mM dNTP) at 30 oC. After 
4 hours, primer 2 and primer 3 (50 M) were added to the reaction to initiate the 
multi-primed chain reaction for another 16 hours, which resulted in a DNA hydrogel 
composed of scudDNA. The scudDNA was isolated from the hydrogel by 
mechanically breaking the DNA bundles between them. The isolated scudDNA was 
then purified by repeatedly centrifuging at 8000 rcf (2 min) and washing with milliQ 
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water 3-4 times, until no absorption at 260 nm was detected in the supernatant. The 
obtained scudDNA was dispersed in milliQ water and stored at 4 
o
C. By simply using 
Cy5 or Alexa 488-labled primer 2, red or green fluorescent scudDNA was produced. 
To reveal the microstructure of the scudDNA, it was coated with Au/Pd and imaged 
by the LEO 1550 FESEM (Carl Zeiss). The composition of scudDNA was examined 
by incubating it with the inorganic pyrophosphatase (0.01 unit/l) in the reaction 
buffer (40mM Tris-HCl, 10mM MgCl2) at room temperature. The optical density at 
600 nm was measured by a microplate reader (BioTek Instruments) every hour. 
Elemental analysis of the scudDNA was carried out using a Tecnai T12 TEM (FEI). 
3.2.3 scudDNA mass, density and dose calculation 
The mass of each scudDNA was quantified using the following method. First, 
the number of scudDNA in the solution was counted using a hemocytometer. Then the 
scudDNA was treated with excess amounts of Exonuclease I and Exonuclease III for 
24 hours to totally degrade the DNA into nucleotides. After digestion, the absorbance 
by the nucleotides at 260 nm was measured and the concentration was determined 
according to the standard nucleotide absorption curve. The average mass of each 
scudDNA was determined to be 0.15 pg, through dividing the nucleotide concentration 
by the number density of the scudDNA in solution.  
Since most of the scudDNA had a spherical morphology, the formula for the 
volume of a sphere was used to estimate volume of the scudDNA. The scudDNA had 
an average diameter of 1.3 m (Figure 3.2), and the volume of the scudDNA was 
calculated to be 1.15 m3. Thus, the average density of the scudDNA was 0.13 
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pg/m3. 
The compaction ratio and CpG dose in each scudDNA was calculated as 
followings: 
• Mass of the 82 base immune DNA template  
= 25088 g/mol = 25088/(6.02×10
23
) = 4.17×10
-8
 pg 
• Average repeating immune DNA template in each scudDNA  
= 0.15pg/(4.17×10
-8 
pg) = 3.6×10
6
 
• Average compaction ratio  
= 3.6×10
6
×82(base)×0.34(nm/base)/(1300nm) = 7.7×10
4
 
• Average molecular weight of each scudDNA  
= 3.6×10
6
×25088 (g/mol) = 9×10
10
 g/mol 
Since each immune DNA template contains two copies of CpG motif  
• Average CpG motif in each scudDNA  
= 3.6×10
6
×2 = 7.2 million 
3.2.4 In vitro immunostimulatory effects of the scudDNA 
Mice macrophage cell line Raw 264.7 was maintained in Dulbecco's Modified 
Eagle Medium (DMEM), with 10 % fetal bovine serum (FBS) and 1% 
penicillin/streptomycin. Before the experiment, cells were seeded in a 48-well cell 
culture plate at a density of 160,000/well. After overnight incubation, the cell culture 
medium was discarded and the cells were subjected to scudDNA
+CpG
 or shortDNA
+CpG
 
for the potency and stability test. To test the potency of the scudDNA
+CpG
 and 
shortDNA
+CpG
, Opti-Modified Essential Medium (Opti-MEM, a reduced-serum 
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medium, 200 l) with different concentrations of scudDNA+CpG or shortDNA+CpG (1, 
2.5, 5 and 10 g/ml, equal to 80, 200, 400 and 800 nM of CpG motif) were added to 
the cells. After 8 h (for TNF-) or 24 h (for IL-6) incubation, the supernatant was 
collected and stored at -80 
o
C for later use. On the other hand, to test the stability of 
the scudDNA
+CpG
 and shortDNA
+CpG
 against serum degradation, the DNA samples 
were pretreated in 200 l DMEM with 10 % FBS for different amounts of time (0, 2, 
4, 8, 16 and 24 hours) with a concentration of 5 g/ml at 37 oC. The serum treated 
scudDNA
+CpG
 and shortDNA
+CpG
 were either examined by agarose gel electrophoresis 
to check their stability or incubated with the Raw 264.7 cells for 8 h (for TNF-) or 24 
h (for IL-6) to test their immunostimulatory functions. Measurements of the secreted 
TNF- and IL-6 (n ≥ 3) were determined by the ELISA according the provided 
protocols. The DNA degradation was quantified by Image-J.  
3.2.5 Cell uptake and release of the scudDNA 
Raw 264.7 cells were seeded in a 4-well chamber slide (Thermo Fisher 
Scientific) at a density of 170,000/well and cultured overnight. Red fluorescence 
labeled scudDNA
+CpG
 (0.75 g, equal to 29 scudDNA/cell) in 400 l DMEM with 10 
% FBS was added to the well and incubated at 37 
o
C or 4 
o
C for 8 h. The cells were 
then washed with 500 l PBS for 3 times, and fixed with 4 % paraformaldehyde in 
PBS for 15 min. After incubating with 0.1 % Triton-X-100 in PBS for 4 min, the cells 
was stained with Alexa-488 Phalloidin (Life Technologies) to visualize the 
filamentous actin according to the provided protocol. The slide was then incubated 
with DAPI (250 ng/ml in PBS) to stain the cell nuclei. Prolong Gold anti-fade solution 
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was dropped onto the slide to avoid fluorescence bleaching. The slide was sealed with 
nail polish and imaged with LSM710 confocal microscopy (Carl Zeiss). To test 
whether the scudDNA
+CpG
 was colocalized with the endo-lysosome, we used a 4-well 
cell culture dish with glass bottom (CELLview, Greiner Bio-One). Cells were seeded 
at a density of 80,000/well and cultured overnight, and then incubated with green 
fluorescence labeled scudDNA
+CpG
 (0.35 g, equal to 29 scudDNA/cell) in 200 l 
DMEM with 10 % FBS at 37 
o
C for 8 h. After that, the cells were washed with 
DMEM for 3 times and incubated with deep red LysoTracker (Life Technologies, 
15,000X dilution of the stock) in DMEM for another 2 h at 37 
o
C. Hoechst 34580 
(Life Technologies, 1 g/ml) was then added to the cells to stain the nuclei for 30 min. 
The live cells were imaged under the LSM710 confocal microscopy.  
To test the release of the scudDNA
+CpG
, the scudDNA
+CpG
 was incubated with 
100 mM PBS buffer (pH = 7.4, 6.5 and 6.0) or 100 mM sodium acetate buffer (pH = 
5.5, 5.0, 4.5 and 4.0) for 2 hours at 37 
o
C. The solution was briefly centrifuged to 
collect the leftover scudDNA
+CpG
. The DNA released was quantified by measuring the 
absorbance at 260 nm in the supernatant.  
3.2.6 Toxicity of the scudDNA 
The toxicity of scudDNA
+CpG
 was examined both in vitro and in vivo. To test 
the in vitro toxicity, scudDNA
+CpG
 of different concentrations (0.1, 1, 5, 10 and 20 
μg/ml) was incubated with the Raw 264.7 cells overnight. The cell viability was 
assessed by the MTT assay. To test the in vivo toxicity, scudDNA
+CpG
 (10 g, 50 μL) 
was subcutaneously injected into the right flank of the 6-week-old female BALB/c 
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mice (n = 6 for each group) at a frequency of two injections per week for three weeks. 
PBS was used as a control. The mice were sacrificed at day 21. Blood samples were 
collected from the mice fundus artery and centrifuged at 3000 rpm for 30 min to 
separate blood cells and blood plasma. Major organs including livers, kidneys and 
spleens were also harvested, fixed in 4 % formalin/PBS solution, embedded in OCT 
resin, and then sectioned and stained with hematoxylin/eosin. The blood biochemistry, 
hematological analysis and histological examinations of different organs were 
examined to assess the in vivo toxicity.  
3.2.7 In vivo tumor suppression of the scudDNA 
The mice colon tumor cancer cell line (CT26.WT) was maintained in RPMI 
1640 media supplemented with 10 % FBS. The tumor cells (1×10
6
) were 
subcutaneously injected into the right flank of the 6-week-old female BALB/c mice. 
The tumor was allowed to grow for one week (at which time the size reached ~ 2 mm 
in diameter). The mice were then weighed, randomly coded and divided into four 
different groups (n = 8 for each group). PBS, control shortDNA
+CpG
, control 
scudDNA
-CpG
 or scudDNA
+CpG
 (10 g, 50 μL) was intratumorly injected into the mice 
at a frequency of two injections per week for three weeks. The tumor size was 
measured every three days. Tumor volume was estimated according to the formula V 
= 0.52ab
2
, where a is the largest superficial diameter and b is the smallest superficial 
diameter. To monitor the tumor weight, the mice was sacrificed by cervical 
dissociation one week after the treatment was finished, and the tumors were removed 
from the mice and weighed. To monitor the survival rate, another group of mice (n = 
8) was cultured for another seven weeks after the treatment was finished and the 
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number of dead mice was recorded.  
3.2.8 In vivo tracking of the scudDNA 
To label the scudDNA
+CpG
 with tissue-penetrating infra-red quantum dots 
(Ag2S QD), 5’ amine modified primer 2 (160 M) was first conjugated to carboxylic 
group modified QD (4 M) catalyzed by the 1-Ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC, 2 mM) and N-Hydroxysuccinimide (NHS, 2 mM) in pH = 7.4 
PBS buffer for 6 hours. The conjugated DNA-QD was purified by removing the free 
DNA, EDC and NHS using the YM-50 centrifuge column (Mw = 50,000 cutoff 
membrane, Millipore) for 3-4 times, until no DNA was detected in the flow-through 
solution. The QD-DNA was added to the MCA reactions to produce the QD-labeled 
scudDNA
+CpG
. The QD-labeled shortDNA
+CpG
 was obtained using a similar method. 
The QD-scudDNA
+CpG
 or QD-shortDNA
+CpG
 (30 g/ml, 50 l) was injected into the 
tumor-bearing mice and the near-infrared fluorescence images were collected in real-
time by a 640×512 pixel two-dimensional InGaAs/SWIR camera (Photonic Science, 
UK) equipped with 880 nm and 1100 nm filters (Daheng Optics and Fine Mechanics 
Co., Ltd, China). A near-infrared lens pair SWIR-35 (Navitar, US) was used to focus 
the image onto the detector. The excitation light was provided by an 808-nm diode 
laser (Starway Laser Inc., China) and the excitation power density at the imaging 
plane was 35.6 mW/cm
2
. 
3.2.9 Data analysis 
Data are expressed as means ± standard deviation. For toxicity study, tumor 
growth and tumor weight, statistical difference was calculated using a one-way Anova 
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method, followed by an unpaired, two-tailed t test. Significance for Kaplan-Meier 
curves was determined by the log-rank test. p-values less than 0.05 were considered 
statistically significant.  
3.3 Results and Discussion 
3.3.1 Formation and mechanism of scudDNA structure 
The scudDNA structure was inspired by a unique enzymatic chain reaction 
reported in our previous bulk-scale DNA hydrogel
154
. For this work, we designed the 
CpG motif into the DNA template (Figure 3.1a & Table 3.1). After two-step 
enzymatic processes: rolling circle amplification (RCA) and multi-primed chain 
amplification (MCA), the DNA template with CpG motif was greatly amplified and 
resulted in a hydrogel with large amounts of uniformly sized DNA microspheres 
(Figure 3.1b-c & 3.1h). More importantly, each of the microspheres was consist of 
unprecedentedly high dose of CpG motif up to several million copies. The 
microsphere was isolated from the hydrogel by mechanically breaking the DNA 
bundles between them (Figure 3.1d, 3.1i & Figure 3.2).  
To our surprise, by measuring the average mass and base number in each 
microsphere, we discovered that the microsphere (i.e. scudDNA) were hugely 
compacted (77000 fold) and reached a density as high as 0.13 pg/m3, which was 
similar to the greatly condensed chromosome DNA in the metaphase of cell circle
170
.  
Unlike chromosomes (or any other traditionally condensed DNA complexes), 
in which DNA was packed by the positively charged reagents such as histones (or 
cationic polymers), our scudDNA was entirely self-condensed without introducing any 
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cationic compacting reagent. This was quite counterintuitive due to the fact that 
negatively charged DNA repelled each other. To understand the underlying process of 
this unusual self-compaction, we carefully examined the RCA and MCA enzymatic 
reactions. During the polymerase catalyzed DNA chain elongation, an SN2 
nucleophilic substitution, the nucleophile was the oxygen of the 3’-hydroxyl group of 
the propagating DNA, and the leaving group was the β and γ - phosphate 
(pyrophosphate) of the dNTP. Upon binding with the Mg
2+
, the metal-bound hydroxyl 
group became more nucleophilic than the sole hydroxyl group. Similarly, another 
Mg
2+
 aided the leaving group, resulting in the generation of a new phosphodiester 
bond along with a pyrophosphate as a byproduct (Figure 3.3). We noted that during 
each step, due to the proximity and participation of the Mg
2+
, magnesium 
pyrophosphate precipitates were generated in situ (as opposed to forming the 
precipitates after the completion of the chain elongation). We also noted that a similar 
metal salt, calcium phosphate, was among the first transfection reagents used for 
condensing DNA
171
. Thus, we speculated that the in situ generated magnesium 
pyrophosphate condensed DNA in real-time.  
Indeed, by incubating the scudDNA with the inorganic pyrophosphatase, an 
enzyme hydrolyzed magnesium pyrophosphate to more soluble magnesium 
phosphate
172
, we observed that scudDNA totally disappeared after the treatment 
(Figure 3.4 a-b). In addition, the optical density 600 (OD 600) gradually decreased 
with increasing incubation time (Figure 3.5). Furthermore, scanning electron 
microscopy (SEM) images showed that, after the pyrophosphatase treatment, the size 
of the scudDNA microsphere diminished and that the microsphere disentangled into 
 75 
fibers (Figure 3.4 c-d). Moreover, elemental analysis data also indicated the presence 
of Mg
2+
 within the DNA microspheres (Figure 3.6). Taken together, these data 
revealed that during the DNA elongation process, extremely long DNA entangled 
while at the same time were self-condensed by magnesium pyrophosphate generated 
in situ.  
We noted that in other polymerase reaction, magnesium pyrophosphate was 
also produced. However, polymerase reaction typically do not condense the DNA, 
which is probably due to the fact that only short DNA strands (in the range of several 
thousand bases, as produced by Taq polymerase) or only small amounts of DNA 
strands (as produced by conventional RCA which lacks the multi-primed chain 
reaction) are produced. Our unique two enzymatic processes not only generated long 
DNA strands (in the range of million bases), but also produced a huge amount of them 
(~1000 fold compared to RCA only). These long DNA strands were entangled with 
each other and condensed by the in situ generated magnesium pyrophosphate, forming 
the scudDNA. Furthermore, co-precipitating the immune DNA template with 
magnesium pyrophosphate failed to produce the scudDNA (data not shown), 
suggesting that in situ condensation was essential for forming such compact structure.  
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Figure 3.2. SEM images and size distribution of the scudDNA. a-c, The scudDNA can 
be prepared in bulk-scale. d, The scudDNA had an average size of 1.3 m. 
 
Figure 3.3. Schematic illustration of magnesium pyrophosphate generated in situ.  
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Figure 3.4. Optical and SEM images of the scudDNA treated with pyrosphosphatase. 
a-b, Light microscopy images of the scudDNA before (a) and after (b) inorganic 
pyrophosphatase. c-d, SEM images of DNA hydrogel before (a) and after (b) 
inorganic pyrophosphatase treatment. The DNA fibers compacted in the scudDNA 
were released after the enzyme treatment.  
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Figure 3.5. Optical density of the scudDNA treated with inorganic pyrophosphatase. a, 
The optical density at 600 nm remained the same for scudDNA without treatment, 
while it gradually decreased for the scudDNA treated with pyrophosphatase b,c, 
Photographs showed clear visual changes that the scudDNA turned from opaque (b) to 
transparent (c) after pyrophosphatase treatment.  
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Figure 3.6. Elemental analysis of the scudDNA. The elemental analysis revealed that 
the scudDNA contained the elements of oxygen, magnesium and phosphorus, furthing 
indicating the presence of magesium pyrophosphate in the scudDNA structure. Other 
elements including carbon and nitrogen are beyond the detection capability of the X-
ray setting in the TEM. Inset: TEM image of the scudDNA. 
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3.3.2 Enhanced immunostimulatory effects of scudDNA structure 
Since each scudDNA comprised 7.2 million copies of the CpG motifs within 
one single microsphere (scudDNA or scudDNA
+CpG
), and since CpG motif was known 
to elicit immune responses, we investigated the immunostimulatory effects of the 
scudDNA by incubating them with the mouse macrophage cells. The single-stranded 
CpG short DNA (shortDNA or shortDNA
+CpG
) with the exact same CpG dose without 
scudDNA structure was used as controls throughout experiments. As expected, both 
scudDNA and shortDNA elicited the immunostimulatory response, characterized by 
the secretion of the TNF- and IL-6 (Figure 3.7 a-b). Surprisingly, the scudDNA 
triggered a much stronger, up to 12 fold TNF- and 88 fold IL-6 stimulatory 
responses compared to the shortDNA control (Figure 3.7 a-b), even though the CpG 
dose used were exactly the same. In addition, little stimulatory effect was observed for 
the scudDNA control, in which the CpG motif was not present in the scudDNA 
structure (scudDNA
-CpG
, Figure 3.7c). These results clearly revealed that it was the 
scudDNA structure alone that greatly enhanced the potency of the CpG motif. For 
both scudDNA and shortDNA, the immunostimulatory effects exhibited generally a 
linear dose response to the concentration tested (from 0 to 800 nM, Figure 3.7 a-b). In 
addition, the CpG dose in each scudDNA can be readily tuned by designing DNA 
templates with different numbers of CpG motif, from 0 - 4 CpG/template, which 
corresponded to 0 - 14.4 million CpG/scudDNA (Figure 3.7c & Table 3.1). As a 
result, we adjusted scudDNA immunostimulatory effects both up and down effectively 
(Figure 3.7c). Moreover, the immune responses from scudDNA were further 
controlled, up and down again with different incubation time (Figure 3.8). Taken 
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together, our results suggested that scudDNA offered a wide window for tuning the 
immune responses by changing the dose per scudDNA, concentration, or incubation 
time. 
In addition to the aforementioned built-in flexibility in tuning the immune 
responses, our scudDNA was stable both structurally and functionally against serum 
degradation.  After 24 hour incubation with serum-containing cell culture media, most 
of the scudDNA was intact, while less than 1% shortDNA control remained (Figure 
3.7d & Figure 3.9). The resistivity to degradation was probably due to the super-
condensed structure that protected the DNA from being totally exposed to enzymes. 
From the functionality perspective, we exposed the scudDNA to the mouse 
macrophage cells after pretreating them for different amount of time. We found out 
that the scudDNA maintained most of the immunostimulatory activities (Figure 3.7 e-
f), while the shortDNA control lost its entire function within 4 hours.  
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Figure 3.7. In vitro immunostimulatory effects of the scudDNA. a-b, TNF- (a) and 
IL-6 (b) secreted by macrophage cells incubated with different concentrations of 
scudDNA
+CpG
 and control shortDNA
+CpG
 (1, 2,5, 5 and 10 g/ml, equal to 80, 200, 
400 and 800 nM of CpG motifs). c, The scudDNA was designed to have different 
doses of CpG motifs (0, 3.6, 7.2 and 14.4 million, respectively). Immunostimulatory 
effects of these four different scudDNA (scudDNA concentration was fixed at 5 
g/ml) was characterized by TNF- secretion. d, Degradation of scudDNA+CpG and 
shortDNA
+CpG
 in 10 % serum-containing cell culture media. e-f, The scudDNA
+CpG
 
and shortDNA
+CpG
 (5 g/ml) were pretreated with 10 % serum-containing cell culture 
media for various time (0, 2, 4, 8, 16 and 24 hours, respectively). The treated 
scudDNA
+CpG
 and shortDNA
+CpG
 were then incubated with the macrophage cells and 
the secreted TNF-(e) and IL-6 (f) were detected. Error bars represent the standard 
deviation.  
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Figure 3.8. Time response curve of the accumulative TNF- secretion. Macrophage 
cells were seeded in 48-well cell culture plate at a density of 40,000/well. After 
overnight incubation, the full cell culture medium was discarded. scudDNA
+CpG
 (10 
g/ml) in 200 l DMEM with 10 % FBS were incubated with the cells for 8 hour and 
10 l supernatant was taken out and stored at -80 oC. The cells were incubated with 
the same media for another 16 hour and the supernatant was carefully replaced by 200 
l fresh DMEM with 10 % FBS. The media was changed every 24 hours and the 
TNF- secreted into the media was quantified by ELISA.  
 
Figure 3.9. Agarose gel images for the degradation of scudDNA. The scudDNA
+CpG
 
(a) and shortDNA
+CpG
 (b) were treated with the 10 % fetal bovine serum.   
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3.3.3 Uptake and release of scudDNA structure 
CpG-based immune responses are mainly governed by the TLR9-mediated 
signal pathways
165
, which require the interaction of CpG motif with the TLR9 located 
in the endosome
167
, as well as maturation and acidification of the endosome
173, 174
. To 
explore whether or not immune cells can uptake our scudDNA without any 
transfection reagent, we first covalently labeled the scudDNA with a red fluorescence 
dye (Cy5, Figure 3.10); we then incubated the labeled scudDNA with the macrophage 
cells. Surprisingly, epifluorescence microscopy revealed that delivery efficiency 
reached 73% (Figure 3.11 a-b & Figure 3.12). The uptake was mainly due to the 
endocytosis, because little uptake was observed when the macrophage cells were 
incubated at 4 
o
C, a temperature that inhibited the endocytosis pathways (Figure 3.11 
b-c). To further demonstrate the endocytosis-based uptake mechanism, we stained the 
cells with Lysotracker, a red dye specifically stained the endo-lysosome, and we 
observed that the green fluorescence-labeled scudDNA (Alex 488, Figure 3.10) was 
colocalized with the endo-lysosome (Figure 3.11 d-g). These results strongly indicated 
that our scudDNA efficiently entered the cell through endocytosis without adding any 
transfection reagent and was located within the endo-lysosome. 
A critical question was how scudDNA, which was super-condensed, triggered 
immune response after endocytosed. We hypothesized that scudDNA self-released 
inside the endo-lysosome at low pH. Indeed, by incubating the scudDNA with 
different buffer solutions mimicking the endo-lysosome pH, we discovered that the 
DNA was gradually released from the scudDNA following the acidification of the 
solutions (Figure 3.11 g). The released DNA fibers from the scudDNA were 
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confirmed by the SEM images (Figure 3.11 h-i). In addition, fluorescence images 
showed that the intact scudDNA swelled at low pH (Figure 3.13). This volumetric 
swelling led to the de-condensing of the scudDNA, concurring to a low pH-triggered 
self-release mechanism. Similar to the aforementioned pyrophosphatase that 
hydrolyzed magnesium pyrophosphate to a more soluble magnesium phosphate, low 
pH also dissolved the magnesium pyrophosphate within the scudDNA, exposing the 
CpG motifs. All these data pointed to a pathway where our scudDNA was first 
endocytosed and then self-released DNA fibers upon low pH. These DNA fibers 
consist of ultra-high dose CpG motifs that were exposed and responsible for the 
interaction with the TLR9, leading towards an enhanced immune response in cultured 
cells. 
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Figure 3.10. Optical microscopy images of the fluorescent scudDNA. Fluorescent 
labeled (cy-5 and Alexa 488) Primer-2 were used to generate fluorescent scudDNA. a-
c, cy5-labeled red fluorescent scudDNA. a, bright field image. b, fluorescence image. 
c, merged image.  d-f, Alexa 488-labeled green fluorescent scudDNA. d, bright field 
image. e, fluorescence image. f, merged image.    
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Figure 3.11. Cell uptake and self-releasing of the scudDNA. a-c, Macrophage cell 
uptake of the red fluorescence labeled scudDNA at 37 
o
C (a) and 4 
o
C (c). The actin in 
the cell was stained with green fluorescent color. Uptake efficiency of the scudDNA 
was quantified at 37 
o
C and 4 
o
C (b). d-g, Colocalization of the scudDNA with the 
endo-lysosome. Bright field microscopy image of the macrophage cells (d). The 
scudDNA was labeled with green fluorescence (e), and the endo-lysosome was stained 
with red fluorescence (f). The yellow fluorescence was the merged color (g), 
indicating that the endocytosed scudDNA was located in the endo-lysosome. The inset 
scale bar was 10 m. h, scudDNA release in different pH buffers. i-j, SEM image of 
scudDNA treated with pH = 7.4 PBS (i) and pH = 4.0 sodium acetate buffer (j). 
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Figure 3.12. Number of scudDNA endocytosed by each cell.  
 
   
Figure 3.13. Fluorescent microscopy images of scudDNA treated with different pH 
buffer. a, pH = 7.4 PBS buffer. b, pH = 4.0 sodium acetate buffer.  
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3.3.4 Toxicity of scudDNA structure 
Encouraged by the promising in vitro results, we tested our condensed DNA in 
vivo as a novel cancer immunotherapy drug. First, cytotoxicity was examined before 
injecting the scudDNA
+CpG
 into the mouse. No cytotoxicity was observed when the 
scudDNA
+CpG
 concentration reached as high as 20 g/ml (equal to 1600 nM CpG 
concentration and 166 scudDNA/cell, Figure 3.14); this was expected mainly due to 
the fact that the scudDNA
+CpG
 was entirely composed of natural poDNA. The absence 
of any transfection reagents also contributed to the low cytotoxicity
171
. Second, 
injecting scudDNA
+CpG
 into the normal mice did not induce any measurable toxicity 
indicated by the blood chemistry, hematological analysis and histological analysis 
(Figure 3.15 & Figure 3.16). 
 
Figure 3.14. Cell viability after treating with scudDNA. Different concentrations of 
scudDNA
+CpG
 were incubated with mouse macrophage cells for overnight. The cell 
viability was evaluated by the MTT assay.  
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Figure 3.15. Blood toxicity of mice treated with scudDNA and PBS.  Blood 
biochemistry (a-f) and hematology analysis (g-o) revealed that no significant 
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difference (determined by two-sample t test assuming unequal variances) was 
observed between scudDNA
+CpG
 treated mice (n = 6) and PBS controls, suggesting 
that scudDNA
+CpG
 did not induce in vivo toxicity. p-value larger than 0.05 was 
considered as not significant. 
 
Figure 3.16. Organ toxicity of mice treated with scudDNA and PBS. The normal mice 
were treated with PBS, or scudDNA
+CpG
. The mice kidney, live and spleen were 
harvested, fixed and sectioned for histological examination. No observable tissue 
damage, necrosis, or inflammation was observed.  
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3.3.5 Suppression of tumor growth in a mouse model by scudDNA structure 
We then used an established murine colon carcinoma model and subjected 
tumor-bearing mice with our murine-specific CpG scudDNA (Figure 1g). Controls 
were scudDNA
-CpG
 and shortDNA
+CpG
. Two days after injection, histology staining 
revealed that in the tumor tissue treated with scudDNA, abundant neutrophils were 
recruited with a great number of necrotic debris presented, indicating an inflammatory 
response was present (Figure 3.17a). On the other hand, few neutrophils were 
observed with obvious large amount of tumor cells for the controls (Figure 3.17 b-d). 
The tumor growth curve indicated an expected increase of tumor volume for the PBS 
control (Figure 3.18a, black squares). Injection of scudDNA
-CpG
 and shortDNA
+CpG
 
controls did not affect tumor growth (Figure 3.18a, blue circles and red triangles, 
respectively). However, injection of our CpG scudDNA almost completely prevented 
the tumor from growing for all the mice (Figure 3.18a, inverted cyan triangles & 
Figure 3.19). Indeed, this dramatic inhibition of tumor growth was visualized by the 
retrieved tumors at day 34 from eight different mice (Figure 3.18b). Similarly, the 
average tumor weight from PBS, scudDNA
-CpG
 and shortDNA
+CpG 
controls reached 
0.4 g after 34 days, respectively. In contrast, the average tumor weight was only 0.07 g 
for CpG scudDNA (Figure 3.18c). The survival rate of the mouse treated with 
scudDNA reached 87.5 % after 80 days, much higher compared to the control mice: 
the survival rate for PBS and scudDNA
-CpG 
was 0 % and 25 %, respectively (Figure 
3.18d). Interestingly, the survival rate of shortDNA
+CpG 
control, which included the 
exact same amount of CpG motifs as our scudDNA, was 0 %, suggesting that both the 
scudDNA structure and the CpG motif were needed as a cancer immunotherapy drug.  
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It was of paramount importance to understand why the scudDNA structure 
enhanced CpG-based immunotherapy in vivo. From this research, at least four unique 
attributes of our scudDNA contributed to the therapeutic effects. First, our scudDNA 
compacted an unprecedentedly high dose of CpG motifs within one unit. Second, the 
condensed structure protected these high dose CpG motifs against serum degradation. 
Third, after uptake, the scudDNA self-released at endo-lysosome low pH and 
intracellular pyrophosphatase. And fourth, the scudDNA displayed superior local 
targeting in vivo (Figure 3.20i). In more detail, scudDNA, labeled with a tissue-
penetrating infra-red fluorescent quantum dot (Ag2S
175
, Figure 3.20a), was 
administered intratumorly; their fate was followed in live animals in real-time (Figure 
3.20b). Even though the same amount of the labeled shortDNA
+CpG 
and scudDNA 
were injected, the labeled shortDNA
+CpG
 rapidly disappeared from the tumor site 
within five minutes and diminished to 16 % after 24 hours (Figure 3.20b & Figure 3. 
20c). In contrast, much more scudDNA were presented at the tumor site within five 
minutes compared to shortDNA
+CpG 
and 76 % still remained even after 24 hours 
(Figure 3.20b & Figure 3. 20c).  
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Figure 3.17. Histology stain of the tumor tissue after scudDNA treatment. a-d, 
Histological stain of the tumor tissue treated with scudDNA
+CpG
 (a), PBS (b), control 
scudDNA
-CpG
 (c), and control shortDNA
+CpG
 (d).   
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Figure 3.18. In vivo suppression of tumor growth by the scudDNA. a, Average tumor 
volume versus time of mice treated with scudDNA
+CpG
 and controls (PBS, scudDNA
-
CpG
 and shortDNA
+CpG
) (n = 8) (P < 0.01). b-c, Images (b) and weight (c) of the 
retrieved tumors at day 34. Scale bar: 2 cm. *** P < 0.001. d, Kaplan-Meier survival 
curves of mice treated with scudDNA
+CpG
 and controls (PBS, scudDNA
-CpG
 and 
shortDNA
+CpG
) (n = 8). scudDNA
+CpG
 increased survival significantly over controls; 
for p-values for all comparisons, determined by log-rank test, see Table 3.2.  
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Figure 3.19. Representative images of tumor-bearing mice after treatment. The mice 
were treated with PBS, control scudDNA
-CpG
, control shortDNA
+CpG
, and 
scudDNA
+CpG
.  Representative images were taken. 
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Figure 3.20. In vivo tracking of the scudDNA. a, Infra-red fluorescent image of the 
PBS and QD-labeled scudDNA
+CpG
. b, Infra-red fluorescent images of the mice 
treated with QD-labeled shortDNA
+CpG
 and QD-labeled scudDNA
+CpG
. c, Normalized 
in vivo infra-red fluorescence intensity of QD-labeled scudDNA
+CpG
 and QD-labeled 
shortDNA
+CpG
 versus time. The infra-red intensities at 30 min, 3 h and 24 h were 
normalized to the infra-red intensity at 5 min. 
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3.4 Conclusion 
We have demonstrated for the first time that a scudDNA structure, which 
compacted more than seven million doses of CpG in a single microsphere, elicited 
much higher immune responses in vitro. In particular, this scudDNA almost 
completely suppressed tumor growth in vivo without causing any measurable toxicity, 
providing an exciting novel DNA-based drug for cancer immunotherapy. Our research 
indicated that a super-condensed DNA physical structure can be effectively used for 
addressing the grand challenge of formulating a very high effective dose without 
causing toxicities. 
Excitingly, our scudDNA is not limited to CpG motifs. Other 
immunostimulatory or immunosuppressive DNA sequences can be easily designed 
into the scudDNA structure. In addition, gene sequence has also been successfully 
employed to produce scudDNA for protein production (data not shown), which can be 
utilized for gene therapy and DNA vaccines. Moreover, by using RNA-dependent 
RNA polymerase, scudRNA can be achieved for RNAi-based therapies. Thus, our 
scudDNA provides a versatile platform to effectively compact and deliver the nucleic-
acid based therapeutics. 
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Table 3.1: DNA sequences for producing the scudDNA. 
Strand Sequence 
Immune DNA 
template 
(shortDNA
+CpG
) 
5’-phosphate-
TAGTTTTCCATGACGTTCCTGACGTTAAGCAGTATTAT
GAACTCTCCATGAGCTTCCTGAGCTTGATGTTCCTAAC
CTACCA 
Primer 1 5’-GTCATGGAAAACTATGGTAGGTTAGGAAC 
Primer 2 5’-AAGCAGTATTATGAACTC 
Primer 3 5’-TGGTAGGTTAGGAACATC 
0 CpG template 5’- phosphate-
TAGTTTTCCATGAGCTTCCTGAGCTTAAGCAGTATTAT
GAACTCTCCATGAGCTTCCTGAGCTTGATGTTCCTAAC
CTACCA 
1 CpG template 5’- phosphate-
TAGTTTTCCATGACGTTCCTGAGCTTAAGCAGTATTAT
GAACTCTCCATGAGCTTCCTGAGCTTGATGTTCCTAAC
CTACCA 
4 CpG template 5’- phosphate-
TAGTTTTCCATGACGTTCCTGACGTTAAGCAGTATTAT
GAACTCTCCATGACGTTCCTGACGTTGATGTTCCTAAC
CTACCA 
  
Table 3.2: P-values determined by log-rank test for survival curve comparisons. 
 PBS 
control 
scudDNA
-CpG
 
control 
shortDNA
+CpG
 
control 
scudDNA
-CpG
 
N.S. --- N.S. 
control 
shortDNA
+CpG
 
N.S. N.S. --- 
 
scudDNA
+CpG
 
0.0004 0.0151 0.0003 
p-value larger than 0.05 was considered as not significant (N.S.). 
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CHAPTER 4: CONCLUSION AND FUTURE PERSPECTIVE 
 
4.1 Conclusion 
A physically entangled bulk-scale DNA hydrogel has been created for the first 
time. The hydrogel is produced from two specially designed enzymatic processes: 
multi-primed chain amplification and rolling circle amplification. These enzymatic 
amplification processes generate a great amount of ultra-long DNA chains and weave 
them together to form a hydrogel. Due to the amplification power of polymerase 
reaction, the DNA hydrogel is synthesized with high efficiency and low cost, and can 
be readily scaled up. Our method provides a novel approach to produce bulk-scale 
DNA materials for real-world application.  
Interestingly, our hydrogel has unusual mechanical properties that are not 
found in nature of any kind: it has both solid-like and liquid-like properties. When the 
gel is immersed in water, it memorizes its original shape and behaves like a solid. 
However, the hydrogel becomes free-flowing “liquid” after taken out of water, and 
metamorphoses back to its original shape upon addition of water. This liquid-to-solid 
transition can be repeated as many times as wanted. The unusually mechanical 
property of the DNA hydrogel is explained by its unique internal hierarchical 
structures and the stresses applied to the hydrogel. The hydrogel is composed of ultra-
long DNA chains, which are not chemically linked but physically entangled with each 
other. This special composition enables the gel to possess an ultra-low elastic 
modulus, while have an extremely high elasticity. Thus, when the gel is taken out of 
water, the gravity and surface tension are able to deform the gel as much as 20 fold, 
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giving the gel to a liquid-like behavior. On the other hand, when the gel is immersed 
in water, the gravitational stress is canceled by the buoyance stress, and the surface 
tension is practically zero, thus the gel returns to its original shape and behaves like a 
solid.  
More interestingly, the hydrogel is composed of a huge amount of uniformly 
sized DNA microspheres. These microspheres can be easily isolated from the DNA 
hydrogel with high efficiency and yield. To our surprise, the DNA density in the 
microspheres reaches as high as the human chromosome density in the metaphase. 
Such high DNA density might be able to condense ultra-high dose of DNA drugs. 
Indeed, by using immunostimulatory CpG drug as an example, we create for the first 
time a super-condensed ultra-high dose DNA (scudDNA) structure, which compacted 
more than seven million doses of CpG in a single microsphere.  
Our scudDNA triggers a significantly enhanced immunostimulatory responses 
in vitro compared to the linear CpG DNA without the scudDNA structure. The 
superior potency is due to the fact that sucdDNA effectively protects the condensed 
DNA, efficiently enters the cell and releases the DNA. More importantly, this 
scudDNA almost completely suppresses tumor growth in vivo without causing any 
measurable toxicity, providing an exciting novel DNA-based drug for cancer 
immunotherapy. On the other hand, linear CpG DNA with the exact same amount 
dose of the scudDNA but without the scudDNA structure does not show any 
therapeutic effect. Our results indicate that this super-condensed physical structure can 
serve as an effectively drug formulation used for addressing the grand challenge of 
formulating a very high effective dose without causing toxicities.  
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4.2 Future perspective 
4.21 Synthesis of the physically entangled DNA hydrogel 
 One of the grand challenges of creating DNA materials for real-world 
applications is how to prepare DNA materials with high yield, large scale and low 
cost. While our physically entangled DNA hydrogel might be able to address this 
challenge, further improvements can be made. The main cost for the physically 
entangled DNA hydrogel is the Φ29 and dNTP. Methods to further reduce the cost are 
desirable.  
 We have demonstrated the gel has a unique internal structure, which results the 
unusual mechanical properties. However, the internal structure is only revealed at the 
nanometer to micrometer scale. Studying the structure from the molecular level, such 
as using labeled primers to track the gel formation process in real time, would greatly 
deepen our understanding in the unique structures and the unusual properties. In 
addition, in the current circular DNA template design, we intentionally avoid any 
secondary structure in the template. While this design greatly helps increase the yield 
of DNA polymerization, it always results in a similar DNA structure. Building 
secondary structures into the template, such as hairpin structures, might be able to 
produce a DNA hydrogel with different internal structure, which may lead to entirely 
different bulk-scale mechanical properties.  
Furthermore, due to the generality of enzymatic reactions, our two-step 
enzymatic amplification processes can be extended to synthesize other nucleic acid 
based hydrogels. For instance, RNA has shown tremendous biomedical application. 
However, preparing RNA materials in bulk scale is even more challenging than DNA 
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materials, because of the fast degradation of RNA as well as the abundance of 
ribonuclease in the environment. Thus, no RNA hydrogel has ever been synthesized so 
far. Our method can be easily applied to the RNA hydrogel synthesis by replacing the 
DNA dependent polymerase to RNA dependent polymerase.  
In addition to the preparing pure nucleic acid material, our DNA hydrogel can 
also be explored in producing hybrid materials. Our DNA hydrogel has a superb 
elastic behavior with up to 2000 % strain. However, the strength of the gel is very low. 
One interesting research direction is whether introducing other materials, such as 
forming interpenetrating network, would be able to increase the strength of the DNA 
hydrogel while maintain its elasticity to achieve ultra-tough and ultra-elastic materials.  
4.22 Applications of the physically entangled DNA hydrogel 
From the macroscopic, no other hydrogels can flow like a liquid as our DNA 
hydrogel. By taking advantage of this unique property, we have demonstrated a circuit 
using water as an electrical switch. Other applications can also be imaged. For 
instance, hydrogels have been utilized for wound healing, due to the facts including 
high water content, porous structure allowing the oxygen penetration, and capability to 
load drugs. However, it is very difficult for the conventional solid hydrogel to totally 
cover the wound, which usually cause the infection of the uncovered wound. Our 
liquid-like DNA hydrogel can easily address this challenge. In addition, different 
drugs can be loaded to the gel either during the gelation process or after the gelation. 
Moreover, our gel is prepared in a physiologically relevant buffer condition, making it 
conveniently to be adapted to the biomedical application.  
From the microscopic, we have isolated the DNA microsphere from the DNA 
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hydrogel, creating a super-condensed ultra-high dose DNA (scudDNA) as a novel 
immunotherapy drug. Besides cancer therapy, our scudDNA can also be used as 
vaccine adjuvant, due to its great potency to trigger the immune system. More 
excitingly, our scudDNA is not limited to immunostimulotary CpG motifs. Other 
immunostimulatory or immunosuppressive DNA sequences can be easily designed 
into the scudDNA structure. In addition, gene sequence has also been successfully 
employed to produce scudDNA for protein production, which can be utilized for gene 
therapy and DNA vaccines. Moreover, by using RNA-dependent RNA polymerase, 
scudRNA can be achieved for RNAi-based therapies. Thus, our scudDNA provides a 
versatile platform to effectively compact and deliver the nucleic-acid based 
therapeutics. 
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